{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2393,"total_is_capped":false,"direct_labels_cover":8,"predictions_cover":2393,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9ec9f971cebb","filters":{"topic":"Psoriasis: Treatment and Pathogenesis"}},"results":[{"id":"W1973354423","doi":"10.1056/nejmoa1314258","title":"Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1964,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Etanercept; Placebo; Dosing; Dermatology Life Quality Index; Clinical endpoint; Internal medicine; Dermatology; Clinical trial; Psoriatic arthritis; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Richard G. Langley","is_ca":true},{"name":"Boni E. Elewski","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"L. Puig","is_ca":false},{"name":"Hidemi Nakagawa","is_ca":false},{"name":"Lynda Spelman","is_ca":true},{"name":"Bárður Sigurgeirsson","is_ca":false},{"name":"Enrique Rivas","is_ca":false},{"name":"Tsen‐Fang Tsai","is_ca":false},{"name":"Norman Wasel","is_ca":true},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Thomas Salko","is_ca":false},{"name":"Isabelle Hampele","is_ca":false},{"name":"Marianne Notter","is_ca":false},{"name":"Alexander Karpov","is_ca":false},{"name":"Silvia Helou","is_ca":false},{"name":"C. Papavassilis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0397480406814782,"gpt":0.3245614633366991,"spread":0.2848134226552209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01401928,0.001738233,0.003541421,0.0005076581,0.0005636122,0.00184558,0.001085333,0.002543557,0.0037634],"category_scores_gemma":[0.008172397,0.0006662466,0.004479413,0.000825549,0.0009689005,0.001117863,0.0005951449,0.003224139,0.0007132459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00114506,"about_ca_system_score_gemma":0.001560582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009222029,"about_ca_topic_score_gemma":0.001709734,"domain_scores_codex":[0.9952135,0.003069593,0.000431455,0.0003727635,0.0005751106,0.0003374576],"domain_scores_gemma":[0.9933215,0.0027637,0.001598988,0.0006340899,0.0007258618,0.0009559162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8206075,0.009315564,0.004133096,0.005905224,0.0121571,0.0001879833,0.0002919179,0.001115428,0.00859778,0.0003368686,0.006768653,0.1305828],"study_design_scores_gemma":[0.8980144,0.07721806,0.01161625,0.0006079682,0.005092713,0.0001959329,0.00004837009,0.0004921758,0.001106325,0.0003841283,0.005178971,0.00004481115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8035862,0.1619918,0.003253622,0.004790064,0.001608164,0.01025053,0.005255206,0.0004317332,0.00883266],"genre_scores_gemma":[0.922587,0.04946359,0.004373063,0.006213618,0.00159659,0.008498231,0.004524642,0.0001282111,0.002615035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01401928,"threshold_uncertainty_score":0.07414192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116956799","doi":"10.1016/s0140-6736(08)60725-4","title":"Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1865,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Internal medicine; Randomization; Randomized controlled trial; Intention-to-treat analysis; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Craig L. Leonardi","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03512843593995436,"gpt":0.2649349371817737,"spread":0.2298065012418194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002839203,0.001979033,0.004402723,0.0005997928,0.0006470726,0.001246563,0.001041706,0.003262415,0.006709111],"category_scores_gemma":[0.002698109,0.001098738,0.002642589,0.0005586148,0.001654836,0.001632065,0.0005130644,0.003900684,0.001239037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000833668,"about_ca_system_score_gemma":0.0007680503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266077,"about_ca_topic_score_gemma":0.00159356,"domain_scores_codex":[0.9989111,0.0005333633,0.00008320464,0.0002071855,0.00009297351,0.0001720555],"domain_scores_gemma":[0.9986932,0.0004294012,0.0003181834,0.0001159906,0.00006762917,0.0003756027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9878683,0.001851612,0.0002950405,0.0004130815,0.0005249092,0.00002075694,0.00002715754,0.0001187997,0.001815604,0.0000256896,0.0003174504,0.006721671],"study_design_scores_gemma":[0.9703646,0.02691396,0.001573929,0.00002273993,0.0004726173,0.00002000128,0.000009550867,0.00008897374,0.0002846994,0.00003935529,0.0001978024,0.00001177623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788167,0.01346628,0.000721868,0.0009886941,0.0005829664,0.001619862,0.001491337,0.0001626246,0.002149645],"genre_scores_gemma":[0.9846485,0.00598669,0.00120023,0.001294888,0.0007202464,0.001418527,0.001375398,0.0000423534,0.003313242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006709111,"threshold_uncertainty_score":0.02244419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004774344","doi":"10.1016/j.chom.2008.09.009","title":"Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine","year":2008,"lang":"en","type":"article","venue":"Cell Host & Microbe","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1748,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Howard Hughes Medical Institute","keywords":"Biology; FOXP3; Lamina propria; Immunology; RAR-related orphan receptor gamma; Cellular differentiation; Microbiology; Cell biology; Immunity; Gut flora; Inflammation; Cell; Intestinal mucosa; Effector; Immune system; Epithelium; Internal medicine","authors":[{"name":"Ivaylo I. Ivanov","is_ca":false},{"name":"Rosa de Llanos","is_ca":true},{"name":"Nicolas Manel","is_ca":false},{"name":"Keiji Yoshinaga","is_ca":false},{"name":"Daniel B. Rifkin","is_ca":false},{"name":"R. Balfour Sartor","is_ca":false},{"name":"B. Brett Finlay","is_ca":true},{"name":"Dan R. Littman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01989031726558024,"gpt":0.1941146353517765,"spread":0.1742243180861963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001446279,0.0002126816,0.0003230861,0.0002592534,0.0002166622,0.0004518784,0.00009879682,0.0003020683,0.00249692],"category_scores_gemma":[0.0002652035,0.0002020025,0.0002490463,0.0001170347,0.0002393968,0.0002332386,0.0003466172,0.0008926453,0.0005024011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001919952,"about_ca_system_score_gemma":0.0003042192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003015774,"about_ca_topic_score_gemma":0.0009206399,"domain_scores_codex":[0.9997488,0.00005753312,0.00001246527,0.00002761325,0.00003600877,0.0001176362],"domain_scores_gemma":[0.9998139,0.00002781489,0.00003416083,0.00001852166,0.00002352279,0.00008211406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006959077,0.00008580735,0.001355154,0.00007721266,0.00000709832,0.0002077922,0.00006488882,0.00003232681,0.9912725,0.0001209363,0.0001100281,0.005970419],"study_design_scores_gemma":[0.0003627818,0.002664261,0.09886181,0.000110969,0.0001420339,0.001837462,0.001998449,0.001087271,0.8840866,0.0008830968,0.007946802,0.00001846689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942389,0.002551172,0.0008397509,0.0001650551,0.00006864438,0.00002430258,0.00007482809,0.00002442324,0.002012894],"genre_scores_gemma":[0.9949914,0.001557887,0.000799364,0.0001143947,0.00004954003,0.00001990396,0.00007617215,0.00001612834,0.002375058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00249692,"threshold_uncertainty_score":0.008353055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998000193","doi":"10.1038/nm1651","title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","year":2007,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1735,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Alberta; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Blood–brain barrier; Inflammation; Central nervous system; Multiple sclerosis; Immunology; Granzyme; Biology; Pathogenesis; Granzyme A; In vivo; Medicine; Neuroscience; Immune system; Granzyme B; T cell; CD8; Perforin","authors":[{"name":"Hania Kébir","is_ca":true},{"name":"Katharina Kreymborg","is_ca":false},{"name":"Igal Ifergan","is_ca":true},{"name":"Aurore Dodelet-Devillers","is_ca":true},{"name":"Romain Cayrol","is_ca":true},{"name":"Monique Bernard","is_ca":true},{"name":"Fabrizio Giuliani","is_ca":true},{"name":"Nathalie Arbour","is_ca":true},{"name":"Burkhard Becher","is_ca":false},{"name":"Alexandre Prat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006146394405878335,"gpt":0.2451548706411168,"spread":0.2390084762352385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004331169,0.0003621456,0.0003062083,0.0003806681,0.0002717633,0.0006669184,0.0001449465,0.0004463885,0.007932379],"category_scores_gemma":[0.000343073,0.0001655364,0.0003806935,0.000204411,0.0002335272,0.0002436572,0.0002718242,0.001546226,0.001817526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001928072,"about_ca_system_score_gemma":0.0003093852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003625802,"about_ca_topic_score_gemma":0.000535716,"domain_scores_codex":[0.9996796,0.000111468,0.00001519791,0.00002969069,0.00004257431,0.0001215509],"domain_scores_gemma":[0.9997858,0.00008048733,0.0000214981,0.00004885632,0.00002235724,0.00004098232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002507497,0.0008765747,0.002093118,0.0001969679,0.00003460185,0.0006275151,0.0001707194,0.0002880619,0.9729091,0.0005804819,0.001470715,0.01824474],"study_design_scores_gemma":[0.0007638769,0.004378418,0.01165874,0.00007640324,0.0001336969,0.00263423,0.0005238162,0.000878828,0.9582778,0.001020027,0.01964075,0.00001341518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864721,0.004732034,0.002074439,0.0003525017,0.0001898307,0.00009643374,0.0003497509,0.00009761403,0.005635331],"genre_scores_gemma":[0.9928495,0.002283417,0.0007311989,0.0002000054,0.0001339021,0.00005370413,0.0004268154,0.00002644296,0.003295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007932379,"threshold_uncertainty_score":0.02653641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045113343","doi":"10.1038/ng.311","title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways","year":2009,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1396,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"National Center for Research Resources; Foundation for the National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; National Institutes of Health; National Heart, Lung, and Blood Institute","keywords":"Psoriasis; Biology; Genetics; Single-nucleotide polymorphism; Genome-wide association study; Genetic association; Gene; Epistasis; Immune system; Genetic predisposition; Immunology; Genotype","authors":[{"name":"Rajan P. Nair","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Cynthia Helms","is_ca":false},{"name":"Jun Ding","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"David E. Goldgar","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Yun Li","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Bing Feng","is_ca":false},{"name":"Andreas Ruether","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Proton Rahman","is_ca":true},{"name":"Steven J. Schrodi","is_ca":false},{"name":"Sampath Prahalad","is_ca":false},{"name":"Stephen L. Guthery","is_ca":false},{"name":"Judith Fischer","is_ca":false},{"name":"Wilson Liao","is_ca":false},{"name":"Pui–Yan Kwok","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"G.M. Lathrop","is_ca":false},{"name":"Carol A. Wise","is_ca":false},{"name":"Ann B. Begovich","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"A. Bowcock","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007429858098225966,"gpt":0.2124438266187554,"spread":0.2050139685205295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000389743,0.0003604917,0.000530859,0.0009162439,0.0003341951,0.0006587335,0.0003779469,0.000412282,0.003203678],"category_scores_gemma":[0.0008127046,0.0002346836,0.0008249277,0.001226001,0.0002997846,0.0001472817,0.000368282,0.0006281455,0.0002772554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001932622,"about_ca_system_score_gemma":0.0003124507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002971934,"about_ca_topic_score_gemma":0.004032214,"domain_scores_codex":[0.9995893,0.00009950001,0.00003048054,0.0001385138,0.00008155701,0.0000606732],"domain_scores_gemma":[0.9992552,0.0002746656,0.0002370201,0.00004879827,0.00005308598,0.0001311541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008269246,0.0002825564,0.6320417,0.0003604352,0.004845948,0.003079769,0.000273307,0.0008139281,0.3188057,0.0004765564,0.002341386,0.02840954],"study_design_scores_gemma":[0.000126948,0.0001725468,0.9897144,0.00001884185,0.001158679,0.002115243,0.0001088371,0.0004815753,0.004474408,0.0003825616,0.001228535,0.0000173475],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938114,0.002163337,0.0007795063,0.0003209225,0.00002152344,0.000008320373,0.001985203,0.00005110416,0.0008586803],"genre_scores_gemma":[0.9974069,0.0006053216,0.000516997,0.0001129895,0.00002085415,0.00001086675,0.0008880036,0.00001661235,0.0004215353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003203678,"threshold_uncertainty_score":0.01071739,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248269869","doi":"10.1016/s0140-6736(08)60726-6","title":"Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1350,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Dosing; Internal medicine; Intention-to-treat analysis; Randomized controlled trial; Adverse effect; Gastroenterology; Immunology; Tumor necrosis factor alpha; Adalimumab","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Mark Lebwohl","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Philippe Szapary","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Ming-Chun Hsu","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Kristian Reich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03514495136420409,"gpt":0.2649833830382751,"spread":0.229838431674071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002848021,0.001979423,0.004298964,0.0006058897,0.0006170648,0.001309669,0.0009547526,0.003268561,0.006720296],"category_scores_gemma":[0.002582941,0.001155125,0.002603848,0.0005697026,0.001483302,0.00154765,0.0004853471,0.003768216,0.001202306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007435179,"about_ca_system_score_gemma":0.0007221423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001213889,"about_ca_topic_score_gemma":0.001549731,"domain_scores_codex":[0.9989116,0.000557485,0.00007404034,0.0002070286,0.00008495457,0.0001649353],"domain_scores_gemma":[0.998828,0.000392614,0.0002652979,0.0001070963,0.00007114133,0.0003359368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9866094,0.001966632,0.0003526994,0.0003980557,0.0006388912,0.00002247515,0.00002961428,0.0001109669,0.002159383,0.00002796104,0.0003497026,0.007334179],"study_design_scores_gemma":[0.9700419,0.02704469,0.001716352,0.00002057343,0.0005145452,0.00002040026,0.00001111304,0.00009789952,0.0002781667,0.00004187608,0.0002014204,0.00001106479],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789058,0.01309827,0.0007861299,0.001080757,0.0006056228,0.001657721,0.001424381,0.0001766708,0.002264627],"genre_scores_gemma":[0.9860525,0.004972059,0.001154818,0.001447705,0.000701596,0.001431826,0.001300619,0.000045259,0.00289352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006720296,"threshold_uncertainty_score":0.02248168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107730744","doi":"10.1136/ard.2004.033217","title":"Psoriasis: epidemiology, clinical features, and quality of life","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1107,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Epidemiology; Disease; Psychosocial; Dermatology; Quality of life (healthcare); Pathology; Psychiatry","authors":[{"name":"Richard G. Langley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2848710214639295,"gpt":0.4508351941802997,"spread":0.1659641727163703,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008186544,0.0009138615,0.002466295,0.001783651,0.0002350883,0.001005158,0.0009094198,0.0009683799,0.001590443],"category_scores_gemma":[0.001045293,0.0002743877,0.0004954696,0.003170251,0.0004174425,0.0008861071,0.0004635312,0.001360294,0.0007343713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005046006,"about_ca_system_score_gemma":0.0008808458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001654719,"about_ca_topic_score_gemma":0.00241386,"domain_scores_codex":[0.9996148,0.00007394296,0.00005929461,0.00007288396,0.0001546275,0.00002431761],"domain_scores_gemma":[0.9993605,0.000254702,0.0001893503,0.00001433498,0.000131322,0.00004982752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001448901,0.0001464186,0.004219771,0.007317403,0.0002353697,0.0001920093,0.00004110442,0.0002864081,0.0005424606,0.0006811784,0.01811265,0.9680802],"study_design_scores_gemma":[0.0002190361,0.0007809373,0.122385,0.02078858,0.00219283,0.01823296,0.0006321368,0.001183422,0.0009377518,0.007071761,0.8253776,0.0001979275],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003290852,0.9988438,0.00009318204,0.0002366152,0.00008339254,0.000003120105,0.00002279984,0.000005214659,0.0003828369],"genre_scores_gemma":[0.004001778,0.9950345,0.0002263374,0.0001455531,0.0003043739,0.000006689871,0.00005539901,6.871903e-7,0.000224789],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002466295,"threshold_uncertainty_score":0.005320549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168911501","doi":"10.1016/s0140-6736(05)67763-x","title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","year":2005,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1069,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Western University","funders":"Amgen","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Etanercept; Psoriasis; Internal medicine; Depression (economics); Physical therapy; Beck Depression Inventory; Adverse effect; Clinical endpoint; Randomized controlled trial; Clinical trial; Psychiatry; Rheumatoid arthritis; Anxiety; Dermatology","authors":[{"name":"Stephen K. Tyring","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Ken Gordon","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Andrea Wang","is_ca":false},{"name":"Deepa Lalla","is_ca":false},{"name":"Michael Woolley","is_ca":false},{"name":"Angelika Jahreis","is_ca":false},{"name":"Ralph Zitnik","is_ca":false},{"name":"David Cella","is_ca":false},{"name":"Ranga Krishnan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07492228636010856,"gpt":0.3600600821513356,"spread":0.285137795791227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002429463,0.00247931,0.006515615,0.0005110058,0.0007543421,0.001448136,0.001452433,0.003618579,0.01005907],"category_scores_gemma":[0.002403753,0.00116866,0.003035343,0.0006508981,0.001694661,0.001360675,0.0005757301,0.0041423,0.001566249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001100023,"about_ca_system_score_gemma":0.001103308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002296198,"about_ca_topic_score_gemma":0.003072487,"domain_scores_codex":[0.999029,0.0004552066,0.00008039635,0.0001973963,0.00007805914,0.0001599461],"domain_scores_gemma":[0.9986277,0.0004626347,0.0003008441,0.0001455291,0.0001034066,0.0003599687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9917505,0.00167476,0.0001573433,0.0005610309,0.0007801967,0.00001759174,0.00001596803,0.00008623554,0.000589066,0.00004073343,0.000405997,0.003920529],"study_design_scores_gemma":[0.9918996,0.00716916,0.0004094253,0.00001676856,0.000221262,0.000008040873,0.00000450063,0.00005414663,0.0000401185,0.00003913776,0.0001332034,0.000004732453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9533833,0.02187664,0.001811531,0.002246272,0.002444967,0.009416718,0.003779836,0.000329638,0.004711128],"genre_scores_gemma":[0.9581279,0.01116967,0.0022346,0.003781875,0.001843462,0.01130387,0.002176507,0.00005413484,0.009307892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01005907,"threshold_uncertainty_score":0.03365088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102889851","doi":"10.1038/ng.2467","title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","year":2012,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1047,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; National Institute for Health and Care Research; Canadian Institutes of Health Research; Versus Arthritis; Medical Research Council; Wellcome Trust","keywords":"Biology; Genome-wide association study; Innate immune system; Psoriasis; Genetics; Candidate gene; Genetic architecture; Immunology; Immune system; Gene; Computational biology; Phenotype; Single-nucleotide polymorphism; Genotype","authors":[{"name":"Lam C. Tsoi","is_ca":false},{"name":"Sarah L. Spain","is_ca":false},{"name":"Jo Knight","is_ca":true},{"name":"Eva Ellinghaus","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"Francesca Capon","is_ca":false},{"name":"Jun Ding","is_ca":false},{"name":"Yanming Li","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Hyun Min Kang","is_ca":false},{"name":"Michael H. Allen","is_ca":false},{"name":"Ross McManus","is_ca":false},{"name":"Giuseppe Novelli","is_ca":false},{"name":"Lena Samuelsson","is_ca":false},{"name":"Joost Schalkwijk","is_ca":false},{"name":"Mona Ståhle","is_ca":false},{"name":"A. David Burden","is_ca":false},{"name":"Catherine Smith","is_ca":false},{"name":"Michael J. Cork","is_ca":false},{"name":"Xavier Estivill","is_ca":false},{"name":"A. Bowcock","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Wolfgang Weger","is_ca":false},{"name":"Jane Worthington","is_ca":false},{"name":"Rachid Tazi‐Ahnini","is_ca":false},{"name":"Frank O. Nestlé","is_ca":false},{"name":"Adrian Hayday","is_ca":false},{"name":"Per Hoffmann","is_ca":false},{"name":"Juliane Winkelmann","is_ca":false},{"name":"Cisca Wijmenga","is_ca":false},{"name":"Cordelia Langford","is_ca":false},{"name":"Sarah Edkins","is_ca":false},{"name":"Robert Andrews","is_ca":false},{"name":"Hannah Blackburn","is_ca":false},{"name":"Amy Strange","is_ca":false},{"name":"Gavin Band","is_ca":false},{"name":"Richard D. Pearson","is_ca":false},{"name":"Damjan Vukcevic","is_ca":false},{"name":"Chris C. A. Spencer","is_ca":false},{"name":"Panos Deloukas","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Stephan Weidinger","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Tõnu Esko","is_ca":false},{"name":"Andres Metspalu","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"H.‐Erich Wichmann","is_ca":false},{"name":"Vinod Chandran","is_ca":true},{"name":"Cheryl F. Rosen","is_ca":true},{"name":"Proton Rahman","is_ca":true},{"name":"Dafna D. Gladman","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"André Reis","is_ca":false},{"name":"Juha Kere","is_ca":false},{"name":"Rajan P. Nair","is_ca":false},{"name":"André Franke","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false},{"name":"Richard C. Trembath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02281824107773177,"gpt":0.2848450931229573,"spread":0.2620268520452255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605542,0.0009528692,0.001554375,0.001350298,0.0001891007,0.001101479,0.0008963818,0.001284006,0.002606213],"category_scores_gemma":[0.0006553755,0.0002531991,0.0005023384,0.001212514,0.0005402307,0.0009432687,0.0006377347,0.002030241,0.001572655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005999446,"about_ca_system_score_gemma":0.000913885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006848488,"about_ca_topic_score_gemma":0.00116926,"domain_scores_codex":[0.9997855,0.00002620049,0.00003145502,0.0000525889,0.00007999739,0.00002432246],"domain_scores_gemma":[0.9995448,0.0001924735,0.00007702969,0.00001688727,0.0001127091,0.00005610285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001385096,0.00005714438,0.0005052262,0.004600606,0.00008152047,0.0005045232,0.00002358157,0.0002357807,0.007080963,0.002122071,0.0201762,0.9644739],"study_design_scores_gemma":[0.00007501253,0.0001693685,0.002876074,0.00201244,0.0003377522,0.004905034,0.00005991675,0.0001884704,0.003753336,0.003706498,0.9818681,0.00004798334],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003671621,0.9972626,0.0005800698,0.0006349907,0.0002830605,0.000004144487,0.00003206237,0.00002115896,0.0008147534],"genre_scores_gemma":[0.001984673,0.9949826,0.0007748972,0.0006673565,0.0006037541,0.000007784212,0.0001055094,0.00000462093,0.0008687769],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002606213,"threshold_uncertainty_score":0.008718669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172257129","doi":"10.1016/s0140-6736(05)67566-6","title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","year":2005,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1045,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Infliximab; Psoriasis; Medicine; Psoriasis Area and Severity Index; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Dermatology; Surgery; Randomized controlled trial; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Kristian Reich","is_ca":false},{"name":"Frank O. Nestlé","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Jean‐Paul Ortonne","is_ca":false},{"name":"Robert J. Evans","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06806402176190217,"gpt":0.3177268351608078,"spread":0.2496628133989056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002653593,0.001948597,0.006012233,0.0004747943,0.0006376818,0.001376253,0.001554465,0.003034549,0.006478311],"category_scores_gemma":[0.001779892,0.0009305905,0.002536589,0.0005993953,0.001791921,0.001299374,0.0005186867,0.004092809,0.001238412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007976507,"about_ca_system_score_gemma":0.001064891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001152708,"about_ca_topic_score_gemma":0.001633759,"domain_scores_codex":[0.9990879,0.0004238964,0.00006223642,0.0001529033,0.00007913812,0.0001939174],"domain_scores_gemma":[0.9987462,0.0003644363,0.0002520297,0.0001445922,0.00007705142,0.0004156936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986322,0.002124798,0.0002174255,0.0003986011,0.0007140076,0.00002326547,0.00003000817,0.0001118572,0.001553806,0.00005634672,0.000499325,0.007948519],"study_design_scores_gemma":[0.9715256,0.02660758,0.0009506384,0.0000202977,0.0003152492,0.00002306911,0.000009273273,0.0001163933,0.0001226146,0.00004715523,0.0002543981,0.000007685967],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973013,0.01581787,0.001457304,0.001473262,0.00117818,0.003131041,0.001120907,0.0003038133,0.002504713],"genre_scores_gemma":[0.9759945,0.007190987,0.002421216,0.002536448,0.001099431,0.003615471,0.001589372,0.00005338951,0.005499138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006478311,"threshold_uncertainty_score":0.02167213,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2108615089","doi":"10.1067/mai.2001.117929","title":"IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines","year":2001,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":949,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Christie (Canada); Cegep de Sainte Foy","funders":"Medical Research Council Canada; Canadian Lung Association; Medical Research Council; Canadian Thoracic Society","keywords":"Bronchoalveolar lavage; Cytokine; Immunocytochemistry; Immunology; Medicine; Sputum; Chemokine; Eosinophil; Interleukin 8; Peripheral blood mononuclear cell; Interleukin 5; Interleukin; Pathology; Asthma; Inflammation; In vitro; Biology; Lung; Internal medicine","authors":[{"name":"Sophie Molet","is_ca":true},{"name":"Qutayba Hamid","is_ca":true},{"name":"Francis Davoineb","is_ca":true},{"name":"Esra Nutku","is_ca":true},{"name":"Rame Tahaa","is_ca":true},{"name":"Nathalie Pagé","is_ca":true},{"name":"Ron Olivenstein","is_ca":true},{"name":"Jack A. Elias","is_ca":true},{"name":"Jamila Chakir","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02676230942960233,"gpt":0.2977832038162598,"spread":0.2710208943866574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002382533,0.0003108155,0.0002702845,0.00032325,0.0002220674,0.0003604672,0.00009346553,0.0002648821,0.003008662],"category_scores_gemma":[0.000177572,0.0001811455,0.0003140512,0.0001811856,0.0002589278,0.0001286952,0.0002404202,0.0006071583,0.0009278158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001803907,"about_ca_system_score_gemma":0.0001443416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002422366,"about_ca_topic_score_gemma":0.0003751606,"domain_scores_codex":[0.9997991,0.00004286198,0.00001749044,0.0000254204,0.00006080301,0.00005436818],"domain_scores_gemma":[0.9997883,0.00004057292,0.00006060362,0.00001995812,0.00003469784,0.00005594116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003389207,0.00008649169,0.00645052,0.0001310309,0.00001934326,0.0007102133,0.00005625637,0.00001753305,0.9897069,0.00002984168,0.0001246379,0.002328235],"study_design_scores_gemma":[0.0002436737,0.002985886,0.2883303,0.0001652377,0.0002028793,0.00823622,0.0008391899,0.0005471825,0.6831089,0.0001826783,0.01514119,0.00001679236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923759,0.005334306,0.0004987402,0.0001057599,0.00005459459,0.00003429729,0.0002410989,0.00003173445,0.00132362],"genre_scores_gemma":[0.9937018,0.003408372,0.0007586673,0.0001334381,0.00007194277,0.0000947798,0.000540335,0.0000137092,0.001277034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003008662,"threshold_uncertainty_score":0.01006496,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127834887","doi":"10.1056/nejmoa1109017","title":"Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":929,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Placebo; Psoriasis; Internal medicine; Randomization; Gastroenterology; Body surface area; Clinical endpoint; Dose-ranging study; Interleukin 17; Randomized controlled trial; Immunology; Cytokine; Double blind; Pathology","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"Jean‐Paul Ortonne","is_ca":false},{"name":"James G. Krueger","is_ca":false},{"name":"Gregory Kricorian","is_ca":false},{"name":"Girish Aras","is_ca":false},{"name":"Juan Li","is_ca":false},{"name":"Chris B. Russell","is_ca":false},{"name":"Elizabeth H. Thompson","is_ca":false},{"name":"Scott Baumgartner","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02568001421573626,"gpt":0.2981064434153324,"spread":0.2724264291995962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001322884,0.0005834039,0.0009481907,0.0004163636,0.0002259926,0.0004374201,0.0005479016,0.0007029896,0.003487827],"category_scores_gemma":[0.0005792332,0.0003561635,0.0006269777,0.0002200578,0.0003884164,0.0003120075,0.0001602069,0.001446459,0.0008168295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002704454,"about_ca_system_score_gemma":0.0005503668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002037127,"about_ca_topic_score_gemma":0.0009478178,"domain_scores_codex":[0.9996009,0.000180382,0.00002950236,0.00005390549,0.00006819136,0.00006701869],"domain_scores_gemma":[0.9996222,0.00009237792,0.0001147923,0.00002080118,0.00002661611,0.0001232867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3838546,0.05257718,0.01173146,0.003726545,0.002094635,0.000703553,0.0001584262,0.002105322,0.1388901,0.0005622715,0.00756511,0.3960308],"study_design_scores_gemma":[0.7505215,0.2126746,0.01725578,0.000131772,0.0008486406,0.001331195,0.00002922705,0.001062294,0.007213163,0.0001583583,0.008733611,0.00003980853],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711308,0.01894113,0.002027012,0.0008956032,0.0004369392,0.002961586,0.0005603232,0.0001874275,0.002859277],"genre_scores_gemma":[0.9816713,0.008008958,0.003962794,0.001802903,0.0005307228,0.001590432,0.0007019519,0.0000187508,0.001712291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003487827,"threshold_uncertainty_score":0.01166797,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2912058252","doi":"10.1016/j.jaad.2018.11.057","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":924,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Joint (building); MEDLINE; Intensive care medicine","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Daniel H. Kaplan","is_ca":false},{"name":"Darío Kivelevitch","is_ca":false},{"name":"Elizabeth Farley Prater","is_ca":false},{"name":"Benjamin K. Stoff","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Cody Connor","is_ca":false},{"name":"Kelly M. Cordoro","is_ca":false},{"name":"Dawn Marie R. Davis","is_ca":false},{"name":"Boni E. Elewski","is_ca":false},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Matthew Kiselica","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Daniela Kroshinsky","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Jason Lichten","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"Amy S. Paller","is_ca":false},{"name":"Sylvia L. Parra","is_ca":false},{"name":"Arun L. Pathy","is_ca":false},{"name":"Reena Rupani","is_ca":false},{"name":"Michael Siegel","is_ca":false},{"name":"Emily Wong","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Vidhya Hariharan","is_ca":false},{"name":"Craig A. Elmets","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08478409348539527,"gpt":0.3482868694989154,"spread":0.2635027760135201,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003780279,0.001369847,0.003059458,0.005740584,0.0007650297,0.00219371,0.002719883,0.003574821,0.00787614],"category_scores_gemma":[0.005641387,0.0004800672,0.002443588,0.003584154,0.0007326039,0.00138982,0.001472232,0.004276554,0.005509042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00221123,"about_ca_system_score_gemma":0.008246274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00892522,"about_ca_topic_score_gemma":0.01184731,"domain_scores_codex":[0.9977897,0.0004724783,0.0005171009,0.0001397359,0.0008961207,0.0001848509],"domain_scores_gemma":[0.995966,0.001160568,0.000745679,0.00009663279,0.001700916,0.0003301979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001584732,0.0001595904,0.0002477434,0.01594892,0.0001633435,0.0001832227,0.00006075123,0.0003303337,0.0007519981,0.004119616,0.3612978,0.6165782],"study_design_scores_gemma":[0.00007715382,0.00006689701,0.0009500844,0.01561175,0.0002817007,0.0005586153,0.00003412551,0.0001020974,0.0001841791,0.001766714,0.9803421,0.00002449955],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009930868,0.9808828,0.0009119929,0.005824422,0.00465339,0.0001434232,0.0004620116,0.00008630902,0.006936244],"genre_scores_gemma":[0.0008855093,0.9819347,0.003766581,0.006338395,0.002086022,0.0002104796,0.0009807096,0.00002248756,0.003775099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00892522,"threshold_uncertainty_score":0.02634829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211202219","doi":"10.1038/nrdp.2016.82","title":"Psoriasis","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":897,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Psoriasis; Dermatology; Medicine","authors":[{"name":"Jacqueline Greb","is_ca":false},{"name":"Ari M. Goldminz","is_ca":false},{"name":"James T. Elder","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Jashin J. Wu","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"A.Y. Finlay","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03310098136570067,"gpt":0.3281866627955874,"spread":0.2950856814298868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002593701,0.0008584379,0.0007618386,0.001202662,0.0005288125,0.001791889,0.0005396969,0.001300008,0.1174121],"category_scores_gemma":[0.0006911956,0.0002448334,0.0004049342,0.0008527154,0.0003039629,0.0007113656,0.001145394,0.001976771,0.1028577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003073077,"about_ca_system_score_gemma":0.000579038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007894081,"about_ca_topic_score_gemma":0.001393092,"domain_scores_codex":[0.9997655,0.00003344686,0.0000176287,0.00004706443,0.00009595073,0.00004048812],"domain_scores_gemma":[0.9998503,0.00002233385,0.00001927865,0.00001957864,0.00004869062,0.00003974239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009160518,0.00005157919,0.0001117108,0.001303952,0.0000182554,0.0003115246,0.00003137013,0.00005728013,0.003915914,0.003273481,0.237518,0.7533154],"study_design_scores_gemma":[0.00002037514,0.00002520157,0.0001967736,0.0003148979,0.0000127836,0.001020227,0.00001463605,0.00002303097,0.0006578595,0.0007012823,0.997008,0.000004873421],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001650645,0.5823801,0.005256384,0.005783694,0.01269902,0.0002411185,0.001603019,0.00135029,0.3890358],"genre_scores_gemma":[0.02391007,0.4019905,0.003404828,0.01082835,0.005354621,0.0001835794,0.003473375,0.0001787705,0.5506758],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1174121,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063627867","doi":"10.1016/j.jaad.2007.09.010","title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":883,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Randomized controlled trial; Dermatology; Physical therapy; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Bruce Strober","is_ca":false},{"name":"Martin Kaul","is_ca":false},{"name":"Yihua Gu","is_ca":false},{"name":"Martin M. Okun","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02011710880311059,"gpt":0.3155302584066383,"spread":0.2954131496035277,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431842,0.002675269,0.005402266,0.0004582035,0.0008061719,0.001713285,0.001292606,0.002161944,0.007659015],"category_scores_gemma":[0.001821894,0.001039871,0.002624938,0.0005213957,0.001664323,0.001424301,0.0005238256,0.004013145,0.001544042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008420451,"about_ca_system_score_gemma":0.001203712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266761,"about_ca_topic_score_gemma":0.002576887,"domain_scores_codex":[0.999127,0.0004178561,0.00005026235,0.000163159,0.00006973313,0.0001721342],"domain_scores_gemma":[0.9990461,0.0002935262,0.0001779766,0.00008705345,0.00006588936,0.000329455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9819236,0.00268614,0.0003636091,0.0008872365,0.001536583,0.00004177176,0.00004139419,0.0002163882,0.001353242,0.0001094554,0.001065493,0.00977507],"study_design_scores_gemma":[0.9886508,0.009636124,0.0006111157,0.00002439269,0.0004192858,0.00002049471,0.00001076186,0.0001217509,0.00007693101,0.00009146925,0.0003296304,0.000007193255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9530674,0.02508363,0.002305523,0.00265314,0.002355745,0.006859012,0.002348769,0.0004448993,0.004881801],"genre_scores_gemma":[0.9696732,0.008878431,0.003207203,0.003282015,0.001045544,0.005683529,0.001936548,0.0000629597,0.006230603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007659015,"threshold_uncertainty_score":0.02562195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2570141807","doi":"10.1016/j.jaad.2016.11.041","title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":860,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Adalimumab; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Internal medicine; Placebo; Adverse effect; Surgery; Gastroenterology; Dermatology","authors":[{"name":"Andrew Blauvelt","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"B. Randazzo","is_ca":false},{"name":"Yasmine Wasfi","is_ca":false},{"name":"Yaung‐Kaung Shen","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03413351889159199,"gpt":0.3233729633831536,"spread":0.2892394444915616,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003367701,0.001305646,0.002412334,0.0003677801,0.0003656981,0.001124018,0.0008075305,0.001565831,0.004182272],"category_scores_gemma":[0.002232046,0.0005459982,0.002118596,0.0002943936,0.001010621,0.0007821096,0.0003393526,0.002797666,0.0006681898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006273599,"about_ca_system_score_gemma":0.000657035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005541359,"about_ca_topic_score_gemma":0.001038114,"domain_scores_codex":[0.9986845,0.0008395176,0.00008691145,0.0001657802,0.0001127803,0.0001105919],"domain_scores_gemma":[0.9985393,0.0004641838,0.0004701269,0.00008309138,0.00007700909,0.0003663002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9802125,0.002490021,0.0008254774,0.0004602576,0.001250874,0.00001605558,0.00003226465,0.0001428732,0.002162674,0.00003316213,0.0003658211,0.01200811],"study_design_scores_gemma":[0.9133201,0.07866468,0.005178634,0.00006155662,0.001159248,0.0000430969,0.00001989473,0.0003098863,0.0006488473,0.00008427331,0.0004961381,0.00001375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819178,0.01407914,0.0004118276,0.0005594323,0.0003577842,0.0007880526,0.0007040794,0.00005023114,0.001131693],"genre_scores_gemma":[0.9914384,0.004240502,0.000551693,0.0005943265,0.0004557981,0.0007598206,0.0007717882,0.00001718404,0.001170382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004182272,"threshold_uncertainty_score":0.01781034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149566497","doi":"10.1056/nejmoa0810652","title":"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":851,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Secukinumab; Dermatology; Clearance; Gastroenterology; Adalimumab; Randomized controlled trial; Tumor necrosis factor alpha; Psoriatic arthritis; Urology","authors":[{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Peter van de Kerkhof","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Roseanne Fidelus-Gort","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yichuan Xia","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Neil Goldstein","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02972773026265618,"gpt":0.3047776721716203,"spread":0.2750499419089641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002354143,0.0003862357,0.001820822,0.0004475784,0.0001461005,0.0005226539,0.0004691254,0.0008586326,0.003482847],"category_scores_gemma":[0.002906919,0.0002013861,0.001513429,0.0002525734,0.0003955311,0.0005650409,0.0002170232,0.001052463,0.0003727345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003605302,"about_ca_system_score_gemma":0.0005061735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002436623,"about_ca_topic_score_gemma":0.0006604532,"domain_scores_codex":[0.9983624,0.001099709,0.0001438644,0.00009889127,0.0001688333,0.0001262603],"domain_scores_gemma":[0.9977962,0.001246728,0.0002555142,0.00009364848,0.00007903112,0.0005289295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8827055,0.006109516,0.002796003,0.0008318383,0.00176764,0.0000581301,0.00006686727,0.0008389956,0.005961663,0.0002137791,0.0004797047,0.09817046],"study_design_scores_gemma":[0.5211458,0.434119,0.0329189,0.0002575463,0.002208871,0.000370997,0.00009768071,0.001828873,0.002993693,0.0007561517,0.00326741,0.00003522289],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830314,0.01398345,0.0003620896,0.0002874404,0.0002120435,0.0003508965,0.0001483072,0.000023619,0.001600905],"genre_scores_gemma":[0.9963972,0.002204811,0.0003567826,0.000218552,0.0001959216,0.000132968,0.00010929,0.000003972306,0.0003806108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003482847,"threshold_uncertainty_score":0.01245004,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2418506270","doi":"10.1056/nejmoa1512711","title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":838,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Psoriasis; Etanercept; Placebo; Plaque psoriasis; Clinical trial; Interleukin 17; Dermatology; Internal medicine; Tumor necrosis factor alpha; Alternative medicine; Secukinumab; Inflammation; Psoriatic arthritis; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":true},{"name":"Andrew Blauvelt","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Thomas A. Luger","is_ca":true},{"name":"Mamitaro Ohtsuki","is_ca":true},{"name":"Kristian Reich","is_ca":true},{"name":"David A. Amato","is_ca":true},{"name":"Susan Ball","is_ca":true},{"name":"Daniel Braun","is_ca":true},{"name":"Gregory S. Cameron","is_ca":true},{"name":"J. Erickson","is_ca":true},{"name":"Robert J. Konrad","is_ca":true},{"name":"Talia M. Muram","is_ca":true},{"name":"Brian J. Nickoloff","is_ca":true},{"name":"Olawale Osuntokun","is_ca":true},{"name":"Roberta J. Secrest","is_ca":true},{"name":"Fangyi Zhao","is_ca":true},{"name":"Lotus Mallbris","is_ca":true},{"name":"Craig L. Leonardi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04471593433998027,"gpt":0.3116114006828535,"spread":0.2668954663428732,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004583307,0.0008577029,0.001723042,0.0003028556,0.0005627394,0.0007981441,0.0007986637,0.001099682,0.004923496],"category_scores_gemma":[0.002510791,0.0003896945,0.001623965,0.0003781976,0.0007136192,0.0005147167,0.00049335,0.003387888,0.0005940376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000593358,"about_ca_system_score_gemma":0.001465435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004468698,"about_ca_topic_score_gemma":0.001308327,"domain_scores_codex":[0.9986065,0.0009263102,0.0000818373,0.0001059075,0.0001455962,0.0001339616],"domain_scores_gemma":[0.9981193,0.0005176724,0.0004410532,0.0001645768,0.0001488728,0.0006085031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8785774,0.02019189,0.004906696,0.001767958,0.001905875,0.0001486208,0.0001388554,0.0009187459,0.01187427,0.000499393,0.00830093,0.0707694],"study_design_scores_gemma":[0.8949127,0.09290014,0.005737209,0.00009451998,0.0005170724,0.0001939409,0.00002495818,0.0002974982,0.001013927,0.0005043294,0.003787918,0.00001581176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597977,0.01789124,0.001808035,0.002518733,0.0007508641,0.009077652,0.002396259,0.000174192,0.005585243],"genre_scores_gemma":[0.9761228,0.005573062,0.003061332,0.002588648,0.0006490978,0.007799034,0.001852174,0.00003244166,0.002321483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004923496,"threshold_uncertainty_score":0.02423918,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171889601","doi":"10.1016/s0140-6736(15)60125-8","title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":831,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Etanercept; Placebo; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Clinical trial; Blinding; Interleukin 17; Physical therapy; Dermatology; Psoriatic arthritis; Cytokine; Tumor necrosis factor alpha; Secukinumab; Pathology; Alternative medicine","authors":[{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Peter van de Kerkhof","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"Gregory S. Cameron","is_ca":false},{"name":"J. Erickson","is_ca":false},{"name":"Lu Zhang","is_ca":false},{"name":"Roberta J. Secrest","is_ca":false},{"name":"Susan Ball","is_ca":false},{"name":"Daniel Braun","is_ca":false},{"name":"Olawale Osuntokun","is_ca":false},{"name":"Michael Heffernan","is_ca":false},{"name":"Brian J. Nickoloff","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1149020683539135,"gpt":0.3566539598176311,"spread":0.2417518914637176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002839913,0.001894046,0.00538083,0.0004502443,0.0003578736,0.001710997,0.001161544,0.002735218,0.005520692],"category_scores_gemma":[0.002648519,0.0007780574,0.00480062,0.0004455791,0.001172335,0.001765526,0.0004591041,0.004025876,0.0008070294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008961141,"about_ca_system_score_gemma":0.0007120431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001222353,"about_ca_topic_score_gemma":0.001684387,"domain_scores_codex":[0.9989491,0.0005045334,0.0001007396,0.0001865848,0.00009173516,0.000167303],"domain_scores_gemma":[0.9986675,0.0006821236,0.0002827274,0.00008718792,0.00006062401,0.0002198415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9802157,0.0009203554,0.0002499099,0.001378357,0.002230678,0.00002909388,0.00003587023,0.0002044127,0.0009735191,0.0001105772,0.0005327106,0.0131187],"study_design_scores_gemma":[0.9740138,0.02206123,0.001201496,0.0001072851,0.00142069,0.00003668578,0.00002835195,0.000169556,0.0001644323,0.0002379118,0.0005434373,0.00001519281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.90271,0.08164968,0.001572615,0.002618151,0.002694692,0.002044612,0.001904434,0.0002230677,0.004582708],"genre_scores_gemma":[0.9714415,0.01791836,0.001410995,0.001881125,0.001093908,0.001353001,0.001124042,0.00004603324,0.003731018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005520692,"threshold_uncertainty_score":0.01846856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326643498","doi":"10.1056/nejmoa1503824","title":"Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":806,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"XLV Diagnostics (Canada); Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis; Dermatology; Ixekizumab; Internal medicine; Secukinumab; Psoriatic arthritis; Disease; Infliximab","authors":[{"name":"Mark Lebwohl","is_ca":true},{"name":"Bruce Strober","is_ca":true},{"name":"Alan Menter","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Jolanta Węgłowska","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Kim Papp","is_ca":false},{"name":"Lynda Spelman","is_ca":true},{"name":"Darryl Toth","is_ca":true},{"name":"Francisco A. Kerdel","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Georg Stingl","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"H. Bachelez","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Jeffrey Crowley","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Tomasz Blicharski","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"J.‐P. Lacour","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Jerry Bagel","is_ca":false},{"name":"John Koo","is_ca":false},{"name":"Gary Aras","is_ca":false},{"name":"Joanne Li","is_ca":false},{"name":"Wenjie Song","is_ca":false},{"name":"Cassandra E. Milmont","is_ca":false},{"name":"Yifei Shi","is_ca":false},{"name":"Ngozi Erondu","is_ca":false},{"name":"Paul Klekotka","is_ca":false},{"name":"Brian L. Kotzin","is_ca":false},{"name":"Ajay Nirula","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07908791848008138,"gpt":0.3240991282479725,"spread":0.2450112097678911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003707445,0.0009234661,0.001864939,0.0005873644,0.0005486839,0.0009863422,0.001054042,0.001474217,0.005223445],"category_scores_gemma":[0.001698745,0.0004931556,0.002428695,0.0005346258,0.0006731562,0.0006468194,0.0003872156,0.003053544,0.0008037576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008433605,"about_ca_system_score_gemma":0.001297413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008420146,"about_ca_topic_score_gemma":0.002284758,"domain_scores_codex":[0.9988921,0.000652242,0.00009239913,0.0001051922,0.0001238854,0.0001342637],"domain_scores_gemma":[0.9981988,0.0006188058,0.0004306787,0.0001280295,0.0001629114,0.0004608828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7751151,0.04583098,0.003796126,0.002896108,0.003383053,0.0001805379,0.0002425421,0.001496548,0.03069752,0.0002807,0.003444952,0.1326358],"study_design_scores_gemma":[0.7071606,0.2759025,0.007747915,0.0001656538,0.001056575,0.0002714668,0.00003868144,0.0004563314,0.003612193,0.0001561987,0.003405693,0.00002625986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9518762,0.03330579,0.001380198,0.001407448,0.0005373342,0.005925772,0.001309763,0.0001751914,0.00408227],"genre_scores_gemma":[0.972903,0.01407729,0.00315039,0.002335321,0.0004708841,0.003669168,0.001492067,0.00003950643,0.001862361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005223445,"threshold_uncertainty_score":0.01960707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071343804","doi":"10.1056/nejmoa062382","title":"A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":785,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Monoclonal antibody; Monoclonal; Immunology; Interleukin 23; Ixekizumab; Interleukin; Interleukin 2; Dermatology; Antibody; Cytokine; Secukinumab; Psoriatic arthritis","authors":[{"name":"Gerald G. Krueger","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Mark Lebwohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03264787616484358,"gpt":0.3145769993690694,"spread":0.2819291232042258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007887912,0.0003255916,0.0005732712,0.0002948388,0.0001635191,0.0002268294,0.0002873142,0.0004382126,0.002650472],"category_scores_gemma":[0.0004814721,0.0001091106,0.0003217827,0.0002004358,0.0002470974,0.0001524199,0.0001454778,0.0009549627,0.0004698604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001672333,"about_ca_system_score_gemma":0.0002672221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001861826,"about_ca_topic_score_gemma":0.0003477706,"domain_scores_codex":[0.9998024,0.00009165579,0.00001752446,0.00002237854,0.00004320328,0.00002289826],"domain_scores_gemma":[0.9998145,0.00005889584,0.00005594181,0.000008413159,0.00001739436,0.00004500787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0971866,0.008444934,0.004431368,0.003169216,0.0009188705,0.0005164102,0.0001033163,0.0009527716,0.09779575,0.0005437776,0.006172641,0.7797644],"study_design_scores_gemma":[0.5208418,0.3360849,0.03237586,0.001092952,0.00205975,0.005846194,0.00009422506,0.001952864,0.03636515,0.0008527072,0.06236263,0.00007090875],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8455439,0.1413754,0.002740099,0.00205111,0.0009072005,0.001454182,0.0002943348,0.0002135427,0.005420309],"genre_scores_gemma":[0.9579127,0.03373829,0.003804888,0.001132091,0.0006703689,0.000811762,0.0003425712,0.00001168452,0.001575595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002650472,"threshold_uncertainty_score":0.008866727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093785176","doi":"10.1182/blood-2009-04-216085","title":"Evidence for a cross-talk between human neutrophils and Th17 cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":761,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Università degli Studi di Verona; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Associazione Italiana per la Ricerca sul Cancro","keywords":"CCL20; C-C chemokine receptor type 6; Chemokine; Interleukin 17; Immunology; Chemotaxis; Tumor necrosis factor alpha; Biology; CCR2; CXCL16; Chemokine receptor; Cell biology; Cytokine; Inflammation; Receptor","authors":[{"name":"Martin Pelletier","is_ca":false},{"name":"Laura Maggi","is_ca":false},{"name":"Alessandra Micheletti","is_ca":false},{"name":"Elena Lazzeri","is_ca":false},{"name":"Nicola Tamassia","is_ca":false},{"name":"Claudio Costantini","is_ca":false},{"name":"Lorenzo Cosmi","is_ca":false},{"name":"Claudio Lunardi","is_ca":false},{"name":"Francesco Annunziato","is_ca":false},{"name":"Sergio Romagnani","is_ca":false},{"name":"Marco A. Cassatella","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05511394460269681,"gpt":0.308155979884125,"spread":0.2530420352814282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006384164,0.0003304493,0.0002071958,0.0003791974,0.0001638991,0.0004176738,0.0002449396,0.0004582104,0.007770048],"category_scores_gemma":[0.000510274,0.0001333883,0.000166457,0.0001703223,0.000179547,0.000222571,0.0004471287,0.0004444458,0.0009912541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001480139,"about_ca_system_score_gemma":0.0001614057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001949819,"about_ca_topic_score_gemma":0.0002357466,"domain_scores_codex":[0.9993302,0.0002845187,0.00004397993,0.0001139706,0.000131364,0.00009601146],"domain_scores_gemma":[0.9996332,0.0001350927,0.00008308552,0.00005198699,0.00005601372,0.00004063799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002027179,0.0004208276,0.01782532,0.001039436,0.0001220239,0.002254001,0.0003176579,0.00006834059,0.9272692,0.002321677,0.001219901,0.04511434],"study_design_scores_gemma":[0.0004793367,0.003903026,0.1740382,0.0005907542,0.0003362407,0.02862138,0.0007191792,0.00106832,0.6400898,0.00210011,0.1480159,0.0000376407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8970354,0.07385135,0.009448441,0.001094907,0.0003310922,0.0002189048,0.0006380244,0.00008037944,0.01730155],"genre_scores_gemma":[0.9774738,0.0116294,0.004597124,0.0005831412,0.0002476141,0.0001392107,0.0006976016,0.0000109086,0.00462127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007770048,"threshold_uncertainty_score":0.02599347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163232748","doi":"10.1111/j.1365-2133.2007.08315.x","title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":722,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Champion; SAINT; Medicine; Nice; Humanities; Library science; Art; Political science; Art history; Law","authors":[{"name":"J.‐H. Saurat","is_ca":true},{"name":"G Stingl","is_ca":true},{"name":"Louis Dubertret","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"J.‐P. Ortonne","is_ca":true},{"name":"Kristina Unnebrink","is_ca":true},{"name":"Martin Kaul","is_ca":true},{"name":"A. Camez","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01153006131279974,"gpt":0.2450423416198201,"spread":0.2335122803070204,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01035626,0.001534342,0.00422554,0.0008198099,0.0004816954,0.001079507,0.0009367982,0.002303893,0.007989733],"category_scores_gemma":[0.0125956,0.0006504597,0.004099812,0.0006584727,0.001169978,0.001033137,0.0004079484,0.002061177,0.000600286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000906958,"about_ca_system_score_gemma":0.00101673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005820889,"about_ca_topic_score_gemma":0.0008160874,"domain_scores_codex":[0.9897086,0.008121951,0.0007228863,0.00058746,0.000583664,0.0002753906],"domain_scores_gemma":[0.9894686,0.005993031,0.002667763,0.0004278076,0.0006763166,0.0007664486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9866723,0.001105832,0.0003365071,0.0007151588,0.002437359,0.00001319674,0.00001736253,0.0001037778,0.0003989313,0.00005261117,0.0002367246,0.007910287],"study_design_scores_gemma":[0.9499905,0.04508187,0.001736471,0.00007961498,0.002257672,0.0000229601,0.00001137692,0.0002532266,0.0001706651,0.00008916965,0.0002952053,0.00001123348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.930757,0.04921631,0.002228731,0.001693461,0.001917811,0.006969595,0.002179472,0.0002112539,0.004826222],"genre_scores_gemma":[0.9780247,0.008831748,0.002644307,0.001237943,0.001525289,0.004990328,0.001226352,0.00003199987,0.001487239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01035626,"threshold_uncertainty_score":0.05476981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146843653","doi":"10.1111/j.1365-2133.2005.06688.x","title":"A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":692,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Probity Medical Research","funders":"","keywords":"SAINT; Medicine; Library science; Family medicine; Art history; Art","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Stephen K. Tyring","is_ca":true},{"name":"M. Lahfa","is_ca":true},{"name":"Jörg C. Prinz","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":true},{"name":"Arline Nakanishi","is_ca":true},{"name":"Ralph Zitnik","is_ca":true},{"name":"P.C.M. van de Kerkhof","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006313327572443979,"gpt":0.2618050005215208,"spread":0.2554916729490769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003806153,0.002038815,0.003560653,0.0006154918,0.00048265,0.001183858,0.0008836788,0.001946079,0.008489746],"category_scores_gemma":[0.002684813,0.0007391009,0.001744734,0.0006256752,0.001466422,0.00104772,0.0004488732,0.002806168,0.00109057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007005131,"about_ca_system_score_gemma":0.001413763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006233025,"about_ca_topic_score_gemma":0.001872473,"domain_scores_codex":[0.9982463,0.001168673,0.00009242045,0.0002322486,0.0001129297,0.0001473594],"domain_scores_gemma":[0.9988421,0.000313103,0.0003378642,0.0001071938,0.00008916332,0.0003106516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9765852,0.00436035,0.0004051824,0.0007657037,0.001054971,0.00002843353,0.00002626328,0.0001830254,0.001828898,0.000115167,0.001252394,0.01339438],"study_design_scores_gemma":[0.9849167,0.01357311,0.0006642126,0.0000190115,0.0001909114,0.00001609446,0.0000044737,0.00009828326,0.00009849541,0.00005316993,0.0003609319,0.000004615055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9248971,0.02710774,0.003694914,0.002657463,0.001625087,0.02639822,0.004454642,0.0007226033,0.008442177],"genre_scores_gemma":[0.9435095,0.0093378,0.006690502,0.005055564,0.001127121,0.02475135,0.003021732,0.00009301688,0.006413456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008489746,"threshold_uncertainty_score":0.02840108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1919283206","doi":"10.1016/j.jaad.2015.03.049","title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":669,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Ortho-McNeil Pharmaceutical; Janssen Pharmaceuticals; Johnson and Johnson; Janssen Biotech; 3M; Merck Sharp and Dohme; Biogen Idec; Genentech; LEO Pharma; Abbott Laboratories; National Institute for Health and Care Research; Sandoz; Novartis; Celgene; Merck; GlaxoSmithKline; Astellas Pharma US; Galderma; Eli Lilly and Company; Pfizer; Amgen; AbbVie; Society of Daughters of the United States Army; Allergan; Merz Therapeutics","keywords":"Apremilast; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Dermatology; Phosphodiesterase inhibitor; Phosphodiesterase; Internal medicine; Pharmacology; Clinical trial; Psoriatic arthritis; Enzyme","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Kristian Reich","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"ChiaChi Hu","is_ca":false},{"name":"Randall M. Stevens","is_ca":false},{"name":"Robert M. Day","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01953649670246773,"gpt":0.3023714075668437,"spread":0.282834910864376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003696112,0.001025714,0.002193668,0.0003285792,0.0003306034,0.000756355,0.000555639,0.001270123,0.003816084],"category_scores_gemma":[0.002317092,0.0004619915,0.001403416,0.0003669996,0.0006560154,0.0006535869,0.000274935,0.002295707,0.0005209555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003841172,"about_ca_system_score_gemma":0.0009287206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003325066,"about_ca_topic_score_gemma":0.0008288414,"domain_scores_codex":[0.9989214,0.0006895685,0.00007928204,0.000127744,0.0001019297,0.0000800613],"domain_scores_gemma":[0.9987326,0.0003712589,0.0003342418,0.00007246812,0.00007773656,0.0004116526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9323584,0.01379126,0.002234111,0.00108683,0.00118687,0.00008118721,0.00007729654,0.0003244651,0.007600672,0.00008292186,0.001358607,0.03981732],"study_design_scores_gemma":[0.8974946,0.09584972,0.004891492,0.00003922493,0.0004187515,0.00008656541,0.00001428981,0.0001735481,0.0004975798,0.00005692854,0.0004679896,0.000009363332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980647,0.0112887,0.0007076762,0.000920249,0.0003169799,0.003280132,0.0008040525,0.0001083898,0.001926916],"genre_scores_gemma":[0.9839965,0.005447375,0.00258158,0.001299535,0.0007334094,0.002953486,0.00125764,0.00001962254,0.001711013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003816084,"threshold_uncertainty_score":0.01954716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2887412253","doi":"10.1016/s0140-6736(18)31713-6","title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":662,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Dermira; Genentech; Celgene; AbbVie; GlaxoSmithKline Australia; Bristol-Myers Squibb; Amgen; Boehringer Ingelheim","keywords":"Medicine; Ustekinumab; Placebo; Psoriasis Area and Severity Index; Internal medicine; Psoriasis; Clinical trial; Randomization; Randomized controlled trial; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Matthias Augustin","is_ca":false},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Yves Poulin","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Howard Sofen","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Mamitaro Ohtsuki","is_ca":false},{"name":"Mary Flack","is_ca":false},{"name":"Ziqian Geng","is_ca":false},{"name":"Yihua Gu","is_ca":false},{"name":"Joaquin Valdes","is_ca":false},{"name":"Elizabeth H. Thompson","is_ca":false},{"name":"H. Bachelez","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05257706308536371,"gpt":0.3200678952590045,"spread":0.2674908321736408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00363189,0.001231134,0.003357812,0.0004079811,0.0004108593,0.001233668,0.0009203912,0.002435458,0.002612107],"category_scores_gemma":[0.002430107,0.0007056655,0.003265024,0.000352741,0.001287493,0.001023238,0.0003532109,0.003282111,0.000625027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006551339,"about_ca_system_score_gemma":0.0007292493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006099063,"about_ca_topic_score_gemma":0.001260611,"domain_scores_codex":[0.9989636,0.0004858751,0.0001084195,0.0001692191,0.0001414872,0.0001315005],"domain_scores_gemma":[0.9985532,0.0005708056,0.0003793415,0.00009579829,0.00009276885,0.0003081144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9211179,0.003821422,0.001847841,0.002570732,0.003249578,0.00008482602,0.0001134726,0.0003399384,0.007599453,0.0001480178,0.001366546,0.05774019],"study_design_scores_gemma":[0.9162026,0.07184571,0.00666052,0.0001086454,0.002065852,0.0001803068,0.00003784655,0.0002580376,0.001101915,0.0002504931,0.001255801,0.00003228939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9438567,0.04879146,0.000630446,0.001104486,0.0005907238,0.001257324,0.0009855554,0.0001401108,0.00264328],"genre_scores_gemma":[0.9814737,0.01224748,0.001105067,0.001389287,0.0006099399,0.0006880263,0.001140868,0.00002430703,0.001321302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00363189,"threshold_uncertainty_score":0.01920748,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050172669","doi":"10.1016/j.jaad.2004.04.012","title":"Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":608,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriasis Area and Severity Index; Inter-rater reliability; Cronbach's alpha; Concordance; Severity of illness; Clinical trial; Physical therapy; Dermatology; Psychometrics; Internal medicine; Rating scale; Statistics; Clinical psychology","authors":[{"name":"Richard G. Langley","is_ca":true},{"name":"Charles N. Ellis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0246171263484653,"gpt":0.3342530989070339,"spread":0.3096359725585686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001496694,0.0005405498,0.0008557131,0.00169992,0.0005567237,0.0005368095,0.0003350785,0.0003551817,0.001493989],"category_scores_gemma":[0.003238416,0.000133647,0.0007846013,0.001146624,0.000234116,0.0006289507,0.0004573852,0.0005699788,0.0003176429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003552819,"about_ca_system_score_gemma":0.000673384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003823312,"about_ca_topic_score_gemma":0.009134735,"domain_scores_codex":[0.9988382,0.0003829847,0.0001583585,0.0001116869,0.000416123,0.00009253454],"domain_scores_gemma":[0.998767,0.0002120518,0.0004541859,0.00004894394,0.0003490709,0.0001687413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001035148,0.0004640777,0.9213033,0.0001716496,0.000423365,0.0002958055,0.0001458829,0.0007383588,0.002296532,0.0001953645,0.002803776,0.07012677],"study_design_scores_gemma":[0.0001583578,0.001267119,0.9894404,0.00005872764,0.000366281,0.002153341,0.0002412048,0.002549535,0.001456006,0.0004495982,0.001831022,0.00002835897],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9596289,0.004062547,0.006166791,0.000769726,0.0001090843,0.0007712437,0.002097001,0.0002130853,0.02618146],"genre_scores_gemma":[0.9855117,0.001400898,0.009174881,0.0002247702,0.000074988,0.0002165692,0.001014624,0.00002352266,0.00235805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003823312,"threshold_uncertainty_score":0.007915318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021674244","doi":"10.1038/ni1439","title":"The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease","year":2007,"lang":"en","type":"article","venue":"Nature Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":604,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Ubiquitin ligase; Experimental autoimmune encephalomyelitis; Inflammation; Signal transducing adaptor protein; Immunology; Signal transduction; Biology; Cell biology; Immune system; Ubiquitin; Gene","authors":[{"name":"Youcun Qian","is_ca":false},{"name":"Caini Liu","is_ca":false},{"name":"Justin Hartupee","is_ca":false},{"name":"Cengiz Z. Altuntas","is_ca":false},{"name":"Muhammet F. Gülen","is_ca":false},{"name":"Dan Jane‐wit","is_ca":false},{"name":"Jianhua Xiao","is_ca":false},{"name":"Yi Lu","is_ca":false},{"name":"Natalia V. Giltiay","is_ca":false},{"name":"Jinbo Liu","is_ca":false},{"name":"Tomasz Kordula","is_ca":false},{"name":"Bruce A. Vallance","is_ca":true},{"name":"Shadi Swaidani","is_ca":false},{"name":"Mark Aronica","is_ca":false},{"name":"Vincent K. Tuohy","is_ca":false},{"name":"Thomas A. Hamilton","is_ca":false},{"name":"Xiaoxia Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008614561718123904,"gpt":0.2342258043554022,"spread":0.2256112426372783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002679719,0.0004482532,0.0003588649,0.0005324997,0.0005613054,0.001047883,0.0003986759,0.000612381,0.00383482],"category_scores_gemma":[0.0004366733,0.0003711819,0.0003194675,0.000210559,0.000413975,0.0004903626,0.0007851633,0.001614569,0.002029961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005212061,"about_ca_system_score_gemma":0.0003134192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002323687,"about_ca_topic_score_gemma":0.0002991442,"domain_scores_codex":[0.9997068,0.00005207742,0.00002261649,0.00004420238,0.00008882954,0.00008540308],"domain_scores_gemma":[0.9995496,0.00004454796,0.0001614865,0.00005458707,0.00004438054,0.0001455415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001150674,0.00005593072,0.002008454,0.00008505981,0.00002184808,0.0004239398,0.00002308302,0.0001587716,0.9901821,0.000701787,0.0006085844,0.004579762],"study_design_scores_gemma":[0.0002007465,0.0003989137,0.08134718,0.0000628937,0.0001359389,0.005745667,0.0002185186,0.003843517,0.8844619,0.001347305,0.02219659,0.0000408913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847361,0.006265768,0.002759647,0.0006841044,0.000186416,0.00002718501,0.000608314,0.0002147832,0.004517641],"genre_scores_gemma":[0.9928923,0.001141631,0.001231121,0.0001660827,0.00005117858,0.00002553107,0.001091799,0.00007713449,0.003323204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00383482,"threshold_uncertainty_score":0.01282871,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152976783","doi":"10.1056/nejmoa030002","title":"A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":580,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Gastroenterology; Immunology; Pharmacology; Plaque psoriasis; Pathology","authors":[{"name":"Mark Lebwohl","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Tiffani K. Hamilton","is_ca":false},{"name":"Darryl Toth","is_ca":true},{"name":"Scott D. Glazer","is_ca":false},{"name":"Naji Tawfik","is_ca":false},{"name":"Patricia A. Walicke","is_ca":false},{"name":"Wolfgang Dummer","is_ca":false},{"name":"Xiaolin Wang","is_ca":false},{"name":"Marvin R. Garovoy","is_ca":false},{"name":"David M. Pariser","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0206780530635987,"gpt":0.2453775974936594,"spread":0.2246995444300607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748909,0.0003697618,0.0005584653,0.0002363931,0.0001820848,0.000266389,0.0002922932,0.0004892789,0.002104538],"category_scores_gemma":[0.0001655844,0.00008839281,0.0002951951,0.0001551734,0.0001682024,0.0002430801,0.0001131095,0.000821295,0.0003962441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001949854,"about_ca_system_score_gemma":0.00015176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001743073,"about_ca_topic_score_gemma":0.0005111003,"domain_scores_codex":[0.9999185,0.00002268668,0.000006365193,0.00001606476,0.00001781051,0.00001875259],"domain_scores_gemma":[0.9999512,0.00001274322,0.00001365843,0.000003125269,0.00000582855,0.00001336029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0256364,0.007355046,0.003357552,0.001642895,0.0003811452,0.001658667,0.000140833,0.0009775945,0.3191229,0.0007466085,0.004531278,0.6344491],"study_design_scores_gemma":[0.2140576,0.291387,0.06343431,0.001173156,0.004107495,0.03167451,0.0002910485,0.008708118,0.22236,0.002309558,0.1603356,0.0001617063],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9171242,0.07253277,0.004181688,0.001176181,0.0003656062,0.0004130517,0.0001469627,0.0002031045,0.003856548],"genre_scores_gemma":[0.975821,0.01770624,0.003658978,0.0006921179,0.0003138497,0.0002018156,0.0002029209,0.00001195743,0.001391194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002104538,"threshold_uncertainty_score":0.007040441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623888527","doi":"10.1016/s0140-6736(17)31279-5","title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":556,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Physical therapy; Gastroenterology; Tumor necrosis factor alpha; Alternative medicine; Pathology","authors":[{"name":"Kristian Reich","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Rodney Sinclair","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Kristine Nograles","is_ca":false},{"name":"Anish Mehta","is_ca":false},{"name":"N. Cichanowitz","is_ca":false},{"name":"Qing Li","is_ca":false},{"name":"Kenneth Liu","is_ca":false},{"name":"Carmen La Rosa","is_ca":false},{"name":"Stuart Green","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1043647610923764,"gpt":0.3656328327658314,"spread":0.261268071673455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002952298,0.002207039,0.00505769,0.0006732771,0.0005251759,0.001683271,0.001230395,0.00298288,0.008362965],"category_scores_gemma":[0.002543051,0.00101139,0.004571047,0.0007033779,0.001500527,0.001826873,0.0005495921,0.004136916,0.001214566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121328,"about_ca_system_score_gemma":0.000893229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001974267,"about_ca_topic_score_gemma":0.003526021,"domain_scores_codex":[0.9985525,0.0007140243,0.0001210707,0.0002429577,0.0001218639,0.0002475904],"domain_scores_gemma":[0.9987073,0.0005334213,0.0003447668,0.0001052263,0.00006916365,0.0002400398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.978243,0.001596023,0.000182202,0.001460697,0.001752753,0.00002748865,0.00004317269,0.000137457,0.001570837,0.00008023709,0.0005878969,0.0143183],"study_design_scores_gemma":[0.9833188,0.01425951,0.0007757625,0.00005837783,0.0008199661,0.00001783108,0.00001625004,0.0000671153,0.0001160975,0.0001161124,0.0004241502,0.00001009337],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.916015,0.06269319,0.001695547,0.002803096,0.002400426,0.005312009,0.003024982,0.0003651364,0.005690767],"genre_scores_gemma":[0.9630449,0.01922516,0.002584495,0.002842546,0.001209023,0.004089811,0.00165649,0.00007610773,0.005271465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008362965,"threshold_uncertainty_score":0.02797693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111980183","doi":"10.4049/jimmunol.170.10.4886","title":"Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment","year":2003,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":530,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cell biology; Signal transduction; STAT1; Chemistry; Biology","authors":[{"name":"Atsunobu Takeda","is_ca":false},{"name":"Shinjiro Hamano","is_ca":false},{"name":"Atsushi Yamanaka","is_ca":false},{"name":"Toshikatsu Hanada","is_ca":false},{"name":"Tatsuro Ishibashi","is_ca":false},{"name":"Tak W. Mak","is_ca":true},{"name":"Akihiko Yoshimura","is_ca":false},{"name":"Hiroki Yoshida","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02701221044402116,"gpt":0.266923352573986,"spread":0.2399111421299649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002171302,0.0006242269,0.0003810063,0.0002623946,0.0002879606,0.0009674306,0.0002980139,0.0007288296,0.008668218],"category_scores_gemma":[0.0001971004,0.0002547729,0.0002836204,0.0001702574,0.0004315599,0.0007400298,0.0003687177,0.001476075,0.002547831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003734804,"about_ca_system_score_gemma":0.0003872885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001462481,"about_ca_topic_score_gemma":0.0003094719,"domain_scores_codex":[0.9998106,0.00002752231,0.00001685305,0.00003186955,0.0000596857,0.00005345907],"domain_scores_gemma":[0.999869,0.00002671296,0.00003005107,0.00001408084,0.00002131387,0.00003886876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00132721,0.0001122646,0.0006971884,0.0007115647,0.0000136079,0.0004364211,0.00004311647,0.0002002273,0.9586376,0.003727627,0.002490938,0.03160229],"study_design_scores_gemma":[0.0001438478,0.0006972076,0.008654579,0.0001566722,0.00006329766,0.001776048,0.0001732305,0.002261919,0.9573454,0.002421744,0.02628968,0.00001642407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8530213,0.09234761,0.01724806,0.00882289,0.002008701,0.0001658386,0.002164069,0.001110473,0.02311093],"genre_scores_gemma":[0.9583334,0.01696596,0.006907687,0.001397313,0.0004751476,0.00005791133,0.001067312,0.00008854668,0.01470669],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008668218,"threshold_uncertainty_score":0.02899808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168384861","doi":"10.1016/j.jaut.2009.12.001","title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","year":2009,"lang":"en","type":"review","venue":"Journal of Autoimmunity","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":518,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Psoriasis; Psoriatic arthritis; Medicine; Epidemiology; Incidence (geometry); Obesity; Demography; Dermatology; Internal medicine","authors":[{"name":"Vinod Chandran","is_ca":true},{"name":"S. P. Raychaudhuri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03600848533808458,"gpt":0.2795983337620942,"spread":0.2435898484240096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006260513,0.000932668,0.002127112,0.002165677,0.0002402275,0.001031653,0.0008760117,0.001240305,0.002195514],"category_scores_gemma":[0.0007872522,0.000314103,0.0005783604,0.002958031,0.0005520459,0.001214544,0.0006266885,0.001334658,0.00110946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004922649,"about_ca_system_score_gemma":0.001015792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00212579,"about_ca_topic_score_gemma":0.003536794,"domain_scores_codex":[0.9997762,0.00004027766,0.00004948183,0.000043347,0.00007039335,0.00002025724],"domain_scores_gemma":[0.9995197,0.0002083579,0.0001035215,0.00001373046,0.000110755,0.0000439006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001390586,0.0001015726,0.00168188,0.008628449,0.0001835645,0.0004613464,0.00006578159,0.000226855,0.0008614915,0.00177795,0.02477744,0.9610946],"study_design_scores_gemma":[0.0000643371,0.0002049457,0.01238552,0.00520469,0.0006265729,0.006698558,0.0002334334,0.0001912761,0.0004213654,0.003018642,0.9708964,0.00005417061],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001236541,0.9991589,0.00006313014,0.0001631652,0.0001845516,0.00000171318,0.000009002982,0.000002311818,0.0002937038],"genre_scores_gemma":[0.001094575,0.9978862,0.0001320072,0.0001241094,0.0004824321,0.000002941126,0.0000218203,5.521466e-7,0.0002553351],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002195514,"threshold_uncertainty_score":0.007344723,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975463338","doi":"10.1016/j.jaad.2006.07.017","title":"A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":517,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Infliximab; Maintenance therapy; Psoriasis; Maintenance dose; Placebo; Randomized controlled trial; Internal medicine; Surgery; Gastroenterology; Chemotherapy; Dermatology; Tumor necrosis factor alpha","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Steven R. Feldman","is_ca":false},{"name":"Gerald D. Weinstein","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Robert J. Evans","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Cynthia M. Arnold","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01481883019480398,"gpt":0.280921689709543,"spread":0.266102859514739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001843717,0.001266985,0.005614369,0.0006967636,0.0005758593,0.001255809,0.001741135,0.002956145,0.007114753],"category_scores_gemma":[0.003061684,0.001001191,0.002469505,0.0007622369,0.001499284,0.001459429,0.0006089755,0.003704329,0.0007331036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001108891,"about_ca_system_score_gemma":0.001007056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002108074,"about_ca_topic_score_gemma":0.003055351,"domain_scores_codex":[0.9987373,0.0005650973,0.0001374423,0.0002556691,0.00009862113,0.0002060544],"domain_scores_gemma":[0.9976904,0.0009179726,0.0004382956,0.0002258077,0.0001211617,0.0006063674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9902393,0.002884136,0.0001568702,0.0001553374,0.0003875241,0.000013344,0.00001631002,0.00007897946,0.0005522341,0.000030586,0.00009375395,0.005391626],"study_design_scores_gemma":[0.9282833,0.06892858,0.001627224,0.0000283778,0.0005548561,0.00001589693,0.00001939551,0.0002103074,0.0001137772,0.00006271309,0.000144391,0.00001123661],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910869,0.005007771,0.0004016591,0.0004702156,0.0007447867,0.001053232,0.0003557653,0.00005849542,0.0008211239],"genre_scores_gemma":[0.993426,0.002003135,0.0008600213,0.0005339287,0.0006105397,0.001059237,0.0003482747,0.00001248592,0.001146525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007114753,"threshold_uncertainty_score":0.02380115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606035821","doi":"10.1056/nejmoa1607017","title":"Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":511,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Interleukin 23; Gastroenterology; Adverse effect; Interleukin 17; Dermatology; Cytokine; Disease","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Andrew Blauvelt","is_ca":true},{"name":"Michael Bukhalo","is_ca":true},{"name":"Melinda Gooderham","is_ca":true},{"name":"James G. Krueger","is_ca":true},{"name":"J.‐P. Lacour","is_ca":true},{"name":"Alan Menter","is_ca":true},{"name":"Sandra Philipp","is_ca":true},{"name":"Howard Sofen","is_ca":true},{"name":"Stephen K. Tyring","is_ca":true},{"name":"B Berner","is_ca":true},{"name":"Sudha Visvanathan","is_ca":true},{"name":"Chandrasena Pamulapati","is_ca":true},{"name":"Nathan Bennett","is_ca":true},{"name":"Mary Flack","is_ca":true},{"name":"Paul Scholl","is_ca":true},{"name":"Steven J. Padula","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268194601443099,"gpt":0.2982235786206202,"spread":0.2555416326061892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001610988,0.000527257,0.002026305,0.000258126,0.0002297922,0.0004983689,0.0003981891,0.0007055935,0.003480241],"category_scores_gemma":[0.001826316,0.0002496421,0.001159627,0.000182901,0.0004947855,0.0004103102,0.0003570193,0.001586671,0.0004624418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003506439,"about_ca_system_score_gemma":0.0007232053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002762119,"about_ca_topic_score_gemma":0.0008383532,"domain_scores_codex":[0.9992061,0.0004475641,0.00008796552,0.00007499095,0.00008977879,0.00009360407],"domain_scores_gemma":[0.9987164,0.0005239013,0.0001946284,0.00005866448,0.00005266118,0.0004537615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8811526,0.007102647,0.002982837,0.0009096875,0.001130768,0.0001304132,0.0001090898,0.001172356,0.0125856,0.0002588365,0.001045484,0.09141971],"study_design_scores_gemma":[0.4295564,0.53707,0.02028506,0.0001874428,0.00168943,0.0006395889,0.0001027475,0.002070379,0.003780902,0.0007122777,0.00386246,0.00004331145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915827,0.005460902,0.0003058026,0.0003675693,0.000249489,0.0004504656,0.0001103084,0.00003331664,0.001439374],"genre_scores_gemma":[0.9966809,0.001465859,0.0005063755,0.0002835223,0.0002303264,0.0002222319,0.00009223576,0.000004168843,0.0005143713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003480241,"threshold_uncertainty_score":0.01164263,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156148414","doi":"10.1016/j.jaad.2013.12.018","title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":511,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Dermatology; Multinational corporation; Family medicine","authors":[{"name":"Mark Lebwohl","is_ca":false},{"name":"H. Bachelez","is_ca":false},{"name":"Giampiero Girolomoni","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"C. Paul","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"P.C.M. van de Kerkhof","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01763577591121485,"gpt":0.2849447469926242,"spread":0.2673089710814093,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001996902,0.0001741422,0.0003772362,0.0005576145,0.000536247,0.0008980698,0.0003650018,0.0008679653,0.001110709],"category_scores_gemma":[0.006630935,0.000230136,0.000716374,0.001325781,0.0002257775,0.0007853815,0.0009634707,0.001033159,0.0001820415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005618369,"about_ca_system_score_gemma":0.0005823178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01479896,"about_ca_topic_score_gemma":0.02238272,"domain_scores_codex":[0.9977515,0.001084345,0.0002945577,0.0001759676,0.0004906754,0.0002030488],"domain_scores_gemma":[0.995988,0.0007752135,0.00215811,0.00009462307,0.0003947321,0.0005894067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007220882,0.00007227068,0.9968582,0.00001550794,0.00006002803,0.00002590652,0.000255523,0.00002758956,0.00003672373,0.000009578588,0.0003017189,0.002264647],"study_design_scores_gemma":[0.000006739021,0.00005049646,0.9989313,0.000008711323,0.00002118644,0.00005459672,0.0006147112,0.00005127029,0.00001149361,0.000008709413,0.0002366578,0.000004134851],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948522,0.0008048751,0.00005100797,0.001173401,0.00002063219,0.00002049318,0.001530711,0.000003689727,0.001542984],"genre_scores_gemma":[0.998052,0.0004692045,0.0001023461,0.0003615978,0.00002792715,0.00001715843,0.0008100237,0.000001941404,0.0001578386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01479896,"threshold_uncertainty_score":0.02942568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008716526","doi":"10.1016/j.jaad.2006.05.027","title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":507,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Open label; Psoriasis; Randomized controlled trial; Double blind; Dermatology; Surgery; Internal medicine; Placebo; Alternative medicine; Tumor necrosis factor alpha","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Darryl Toth","is_ca":true},{"name":"Alan Menter","is_ca":false},{"name":"Sewon Kang","is_ca":false},{"name":"Michael Heffernan","is_ca":false},{"name":"Bruce Miller","is_ca":false},{"name":"Regina Hamlin","is_ca":false},{"name":"Liberata Lim","is_ca":false},{"name":"Rebecca L. Hoffman","is_ca":false},{"name":"Martin M. Okun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03691857886856944,"gpt":0.3417004839563627,"spread":0.3047819050877933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003162861,0.003076186,0.009487017,0.0007466126,0.0009714035,0.001912694,0.001660648,0.00313371,0.008470405],"category_scores_gemma":[0.00277371,0.001451218,0.003492374,0.0008068337,0.002487291,0.00192532,0.0007255096,0.004574047,0.001649696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009341478,"about_ca_system_score_gemma":0.001222537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001255846,"about_ca_topic_score_gemma":0.001615503,"domain_scores_codex":[0.9981784,0.0009117485,0.0001329574,0.0003601073,0.0001401399,0.0002766605],"domain_scores_gemma":[0.9976254,0.0006797655,0.0004833035,0.0002886163,0.0001973097,0.0007255701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9942179,0.00206924,0.000181629,0.0002589616,0.0003753321,0.00001034415,0.00001664241,0.00006715104,0.0005654643,0.00002120412,0.0001546702,0.00206142],"study_design_scores_gemma":[0.9810923,0.01746107,0.0008103645,0.00001106758,0.0002596133,0.000008325543,0.00000726626,0.000123847,0.00007185528,0.00003336693,0.0001125118,0.000008408448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818414,0.005897115,0.001153582,0.0008666177,0.001219276,0.004831078,0.001661444,0.0002460855,0.002283295],"genre_scores_gemma":[0.9806608,0.002817431,0.002124923,0.001481505,0.001371543,0.006014526,0.00151079,0.00004912465,0.003969353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009487017,"threshold_uncertainty_score":0.02833635,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914164523","doi":"10.1016/j.jaad.2018.11.058","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":486,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Janssen Pharmaceuticals; Janssen Biotech; Sandoz; Ortho Dermatologics; LEO Pharma Research Foundation; LEO Pharma; Pfizer; Incyte; Prothena; Novartis Pharmaceuticals Corporation; Dermira; Coherus Biosciences; Valeant Pharmaceuticals International; Janssen Research and Development; XBiotech; UCB; Celgene; Eli Lilly and Company; Allergan; AstraZeneca; Boehringer Ingelheim; Amgen; AbbVie; Sanofi; MedImmune; Merck; National Institutes of Health; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Psoriasis; Guideline; Intensive care medicine; Population; Disease management; Joint disease; Disease; Dermatology; Alternative medicine; Internal medicine; Pathology; Environmental health","authors":[{"name":"Craig A. Elmets","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Dawn Marie R. Davis","is_ca":false},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Jason Lichten","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Cody Connor","is_ca":false},{"name":"Kelly M. Cordoro","is_ca":false},{"name":"Boni E. Elewski","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Daniel H. Kaplan","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Darío Kivelevitch","is_ca":false},{"name":"Matthew Kiselica","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Daniela Kroshinsky","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Amy S. Paller","is_ca":false},{"name":"Sylvia L. Parra","is_ca":false},{"name":"Arun L. Pathy","is_ca":false},{"name":"Elizabeth Farley Prater","is_ca":false},{"name":"Reena Rupani","is_ca":false},{"name":"Michael Siegel","is_ca":false},{"name":"Benjamin K. Stoff","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Emily Wong","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Vidhya Hariharan","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08175444726901368,"gpt":0.3534888795521198,"spread":0.2717344322831061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002659399,0.001260635,0.002414216,0.004747265,0.0007289991,0.001796516,0.002000154,0.003074741,0.00876565],"category_scores_gemma":[0.004828122,0.0003989668,0.001849217,0.002924857,0.0005897544,0.001262793,0.001353027,0.003932524,0.006391339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001601114,"about_ca_system_score_gemma":0.006392008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007108123,"about_ca_topic_score_gemma":0.009698126,"domain_scores_codex":[0.9983347,0.0003392938,0.0003817908,0.0001115355,0.0006814153,0.0001512334],"domain_scores_gemma":[0.9966598,0.0008846874,0.0005601953,0.0000786984,0.00151201,0.0003047176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009416049,0.0001523931,0.0002998383,0.01094768,0.0001131964,0.0002097768,0.00005062786,0.000296517,0.0006614333,0.002834172,0.3541279,0.6302122],"study_design_scores_gemma":[0.00005411144,0.00005471066,0.001265333,0.01417777,0.0002020134,0.0008979828,0.00003921724,0.0001081871,0.0001730348,0.001763149,0.98124,0.00002458113],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001157435,0.9758542,0.001256699,0.006746193,0.005892391,0.0001399319,0.0004305323,0.0001153108,0.009449047],"genre_scores_gemma":[0.001068771,0.9789013,0.004360604,0.006682399,0.003059279,0.0001936419,0.0009762456,0.00002480541,0.004732979],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00876565,"threshold_uncertainty_score":0.029324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996552716","doi":"10.1016/j.cell.2019.11.026","title":"Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease","year":2019,"lang":"en","type":"article","venue":"Cell","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":484,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Alberta Innovates; Damon Runyon Cancer Research Foundation; National Multiple Sclerosis Society; Howard Hughes Medical Institute","keywords":"Biology; Interleukin 17; Immunology; Inflammation; Cell biology; RAR-related orphan receptor gamma; Cytokine; Innate lymphoid cell; FOXP3; Acquired immune system; Immune system","authors":[{"name":"June‐Yong Lee","is_ca":false},{"name":"Jason A. Hall","is_ca":false},{"name":"Lina Kroehling","is_ca":false},{"name":"Lin Wu","is_ca":false},{"name":"Tariq Ahmad Najar","is_ca":false},{"name":"Henry H. Nguyen","is_ca":false},{"name":"Woan-Yu Lin","is_ca":false},{"name":"Stephen T. Yeung","is_ca":false},{"name":"Hernandez Moura Silva","is_ca":false},{"name":"Dayi Li","is_ca":false},{"name":"Ashley M. Hine","is_ca":false},{"name":"P’ng Loke","is_ca":false},{"name":"David Hudesman","is_ca":false},{"name":"J.P. Martin","is_ca":false},{"name":"Ephraim Kenigsberg","is_ca":false},{"name":"Miriam Mérad","is_ca":false},{"name":"Kamal M. Khanna","is_ca":false},{"name":"Dan R. Littman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007569796244783693,"gpt":0.1910738623451584,"spread":0.1835040661003748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002655185,0.0004436739,0.0001930548,0.0003873022,0.0002222175,0.0003409567,0.00008095181,0.0002953353,0.001890829],"category_scores_gemma":[0.0001639431,0.0000889799,0.0002879353,0.0001480882,0.0002201867,0.0001681046,0.0001768937,0.0010903,0.0004423428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001301417,"about_ca_system_score_gemma":0.0002057038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001715959,"about_ca_topic_score_gemma":0.0002518311,"domain_scores_codex":[0.9998186,0.00006561624,0.00001264995,0.00001441912,0.00004606515,0.00004276914],"domain_scores_gemma":[0.9998555,0.00002695178,0.00002571558,0.00001753291,0.00002656601,0.00004763863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001398401,0.0007679518,0.001778095,0.0001707509,0.00003445897,0.0004226899,0.00004922425,0.0001925833,0.9558228,0.0005325474,0.001386777,0.03744369],"study_design_scores_gemma":[0.0008008517,0.007999438,0.0225266,0.00007540045,0.0001367776,0.003333382,0.0003193982,0.00234541,0.9243281,0.001702308,0.03641285,0.00001949314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9727656,0.01186679,0.004727576,0.001059577,0.0007062553,0.00009821037,0.0002033748,0.0002168773,0.008355758],"genre_scores_gemma":[0.9905626,0.003505702,0.001524878,0.0002434255,0.0002757478,0.00003971111,0.0001237949,0.00001740165,0.003706776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001890829,"threshold_uncertainty_score":0.006325483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2514982855","doi":"10.1111/jdv.14386","title":"European consensus statement on phenotypes of pustular psoriasis","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":440,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; European Academy of Dermatology and Venereology; Psoriasis Association","keywords":"Medicine; Psoriasis; Generalized pustular psoriasis; Dermatology; Phenotype; Pustular psoriasis; Clinical trial; Pathology; Genetics","authors":[{"name":"Alexander A. Navarini","is_ca":false},{"name":"A. David Burden","is_ca":true},{"name":"Francesca Capon","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Catherine Smith","is_ca":false},{"name":"Juliet N. Barker","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0838083635548977,"gpt":0.3311105540073089,"spread":0.2473021904524112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02130718,0.001341964,0.002449041,0.004620081,0.001201168,0.004164146,0.0056155,0.008563147,0.01491192],"category_scores_gemma":[0.03025558,0.0008360521,0.004405859,0.003359873,0.001836109,0.002785759,0.004397849,0.008237656,0.01164106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003065847,"about_ca_system_score_gemma":0.009778186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005838591,"about_ca_topic_score_gemma":0.003875931,"domain_scores_codex":[0.9848768,0.004619543,0.003391835,0.001054078,0.004732022,0.001325686],"domain_scores_gemma":[0.9728434,0.007837768,0.002504451,0.001239739,0.01362719,0.00194744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000443374,0.0001535274,0.002007246,0.005775721,0.0001929919,0.001178657,0.0004602843,0.0006297578,0.00177223,0.01992302,0.6801522,0.2873111],"study_design_scores_gemma":[0.0001325006,0.00007204367,0.003241386,0.009891081,0.0001758027,0.001956885,0.0002833811,0.0001881133,0.0006269138,0.007039277,0.9763456,0.00004704507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005749791,0.4388623,0.03896563,0.2551153,0.0582488,0.002832815,0.01694997,0.001464977,0.1818104],"genre_scores_gemma":[0.07422335,0.3910404,0.1228435,0.1929934,0.02303746,0.007998561,0.07168233,0.001640607,0.1145403],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02130718,"threshold_uncertainty_score":0.1126844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114677349","doi":"10.1016/j.jaad.2008.01.006","title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","year":2008,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":431,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Psoriasis; Foundation (evidence); Disease; Intensive care medicine; Population; MEDLINE; Dermatology; Family medicine; Pathology; Environmental health","authors":[{"name":"Alexa B. Kimball","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Elizabeth J. Horn","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Gretchen Korver","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Mark Lebwohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1359285291485051,"gpt":0.4088836466374366,"spread":0.2729551174889315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004495472,0.001110526,0.002747741,0.005097339,0.0006627928,0.00133615,0.002519873,0.002985068,0.004239999],"category_scores_gemma":[0.005706681,0.0005105038,0.001522872,0.003525043,0.0006634147,0.001475974,0.001243823,0.003528158,0.002102623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00189566,"about_ca_system_score_gemma":0.006652671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007339918,"about_ca_topic_score_gemma":0.01037975,"domain_scores_codex":[0.9983694,0.000348188,0.0003704898,0.0001389228,0.000652114,0.0001208819],"domain_scores_gemma":[0.9962347,0.001126605,0.0005768527,0.00007095771,0.00172258,0.0002682977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001253277,0.0001540932,0.0009751935,0.008035528,0.0001426476,0.000252822,0.0000492895,0.00032237,0.0002893205,0.00218206,0.2081642,0.7793072],"study_design_scores_gemma":[0.0001703055,0.0001163953,0.005718902,0.0263793,0.0006466921,0.002598839,0.0001830949,0.0002818773,0.0004069137,0.003812512,0.9596211,0.00006403388],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002245525,0.9817144,0.001223021,0.009698957,0.002534498,0.00008283814,0.000246079,0.00004693989,0.004228722],"genre_scores_gemma":[0.002336634,0.9822283,0.005228314,0.005717924,0.001598771,0.0001387423,0.0007699219,0.00001177707,0.001969626],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007339918,"threshold_uncertainty_score":0.02377462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2892136519","doi":"10.1056/nejmoa1806382","title":"Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":414,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Placebo; Medicine; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Gastroenterology; Clinical endpoint; Tyrosine kinase 2; Clinical trial; Pharmacology; Immunology; Pathology; Receptor; Platelet-derived growth factor receptor","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Kenneth B. Gordon","is_ca":true},{"name":"Diamant Thaçi","is_ca":true},{"name":"Akimichi Morita","is_ca":true},{"name":"Melinda Gooderham","is_ca":true},{"name":"Peter Foley","is_ca":true},{"name":"Ihab Girgis","is_ca":true},{"name":"Sudeep Kundu","is_ca":true},{"name":"Subhashis Banerjee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02193395392893607,"gpt":0.2897631125167306,"spread":0.2678291585877946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001490088,0.001559868,0.001887513,0.0004399528,0.0003220276,0.0006915164,0.0006023142,0.001361666,0.006959349],"category_scores_gemma":[0.000807656,0.0005323919,0.001012119,0.0003226339,0.0006961109,0.0006352896,0.0003430162,0.0026727,0.001039075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000544281,"about_ca_system_score_gemma":0.001083584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005104776,"about_ca_topic_score_gemma":0.001043798,"domain_scores_codex":[0.9996107,0.000178192,0.0000169634,0.00006763225,0.00004443671,0.00008213026],"domain_scores_gemma":[0.9996023,0.00008026729,0.00008836797,0.00003154273,0.0000317411,0.0001658052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8051288,0.04329698,0.002632253,0.00159866,0.001158875,0.0003879125,0.0002158113,0.001812366,0.04293058,0.0006006978,0.008194494,0.0920426],"study_design_scores_gemma":[0.8858911,0.1080332,0.002091274,0.00003131555,0.0001420047,0.0001821444,0.00001777462,0.0005267917,0.001457394,0.000154172,0.00146367,0.000009147755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838822,0.003956076,0.001369147,0.001133004,0.0003953055,0.004820618,0.001468655,0.0002352121,0.002739791],"genre_scores_gemma":[0.9772828,0.003367338,0.002593086,0.002374865,0.000524768,0.007310485,0.002532031,0.00003918747,0.003975546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006959349,"threshold_uncertainty_score":0.02328134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2605632483","doi":"","title":"Diagnosis and management of psoriasis.","year":2017,"lang":"en","type":"review","venue":"PubMed","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":412,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Psoriasis; Psychosocial; Disease; Intensive care medicine; Acitretin; MEDLINE; Observational study; Dermatology; Psychological intervention; Referral; Clinical trial; Physical therapy; Internal medicine; Psychiatry; Family medicine","authors":[{"name":"Whan B. Kim","is_ca":true},{"name":"Dana Jerome","is_ca":true},{"name":"Jensen Yeung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1097961194219535,"gpt":0.3045903520668061,"spread":0.1947942326448526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001153103,0.0008714927,0.001589922,0.002452479,0.0003459883,0.001336455,0.0006460161,0.001421745,0.004620849],"category_scores_gemma":[0.001954611,0.000274138,0.0008502303,0.001498407,0.0005227684,0.001079394,0.0006524626,0.001549571,0.001954637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005843026,"about_ca_system_score_gemma":0.001820716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001285505,"about_ca_topic_score_gemma":0.001489019,"domain_scores_codex":[0.9990593,0.0002506714,0.0001705122,0.0001172013,0.0003518593,0.00005050678],"domain_scores_gemma":[0.999105,0.0003408296,0.0002764999,0.00002606181,0.000203829,0.0000477454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001130884,0.00007980457,0.0005267906,0.08152363,0.0003601823,0.0003380542,0.00007609859,0.0001544541,0.001197308,0.002074595,0.05031525,0.8632407],"study_design_scores_gemma":[0.0001365763,0.000266252,0.004461394,0.0870133,0.001116037,0.01183087,0.0002698179,0.0001738508,0.001026278,0.003481,0.8901843,0.00004032171],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004912362,0.9985721,0.00007078248,0.0004490461,0.0002207095,0.000008034328,0.00001438748,0.000004046168,0.000611843],"genre_scores_gemma":[0.001986376,0.996125,0.0002829081,0.0006937297,0.0005319743,0.00001273003,0.00004477793,0.00000147342,0.0003211234],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004620849,"threshold_uncertainty_score":0.01545829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1661616496","doi":"10.1111/bjd.12214","title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":410,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Mace; Adverse effect; Psoriasis; Population; Internal medicine; Dermatology; Disease; Environmental health","authors":[{"name":"Kim Papp","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Philippe Szapary","is_ca":false},{"name":"Yasmine Wasfi","is_ca":false},{"name":"Daphne Chan","is_ca":false},{"name":"M.-C. Hsu","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Pierre‐Dominique Ghislain","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Kristian Reich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02396324823692888,"gpt":0.2498224002245274,"spread":0.2258591519875985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01562616,0.0005603061,0.001821529,0.0009693307,0.0004923522,0.001226319,0.0004769399,0.0007340179,0.00156337],"category_scores_gemma":[0.009436183,0.0002503602,0.005332911,0.001070651,0.0003318992,0.0009367815,0.0006917538,0.0009678718,0.0002905429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007064171,"about_ca_system_score_gemma":0.0006848622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008986254,"about_ca_topic_score_gemma":0.001357051,"domain_scores_codex":[0.9947877,0.001975231,0.0007991752,0.0005760887,0.001430658,0.0004311675],"domain_scores_gemma":[0.9856866,0.00429508,0.006431585,0.000996495,0.001971943,0.0006183198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04785135,0.00077153,0.8666051,0.001237293,0.0160391,0.0002353554,0.0003439882,0.00181396,0.002621093,0.00007632474,0.000820498,0.06158442],"study_design_scores_gemma":[0.001519369,0.01712048,0.9690102,0.0002175226,0.007858416,0.0004693821,0.00009513122,0.0006569948,0.001277806,0.0001243809,0.001613341,0.00003690167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9709746,0.0239034,0.001349374,0.0001414714,0.00003012009,0.000253908,0.001885518,0.00002988923,0.001431862],"genre_scores_gemma":[0.996427,0.001253568,0.0002636576,0.0001068108,0.00003443769,0.00007494866,0.001658659,0.000004969525,0.0001760797],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01562616,"threshold_uncertainty_score":0.08264005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2618122943","doi":"10.1038/ncomms15382","title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","year":2017,"lang":"en","type":"review","venue":"Nature Communications","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":400,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital; University of Toronto","funders":"National Center for Research Resources; European Regional Development Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institutes of Health; Tartu Ülikool; Heinz Nixdorf Stiftung; Deutsche Forschungsgemeinschaft; Exzellenzclusters Entzündungsforschung; National Research Foundation; King's College London; Psoriasis Association; National Human Genome Research Institute; Wellcome Trust; National Psoriasis Foundation; Helene Morgan Babcock and Alfred Babcock Memorial Scholarship Trust; A. Alfred Taubman Medical Research Institute; Dermatology Foundation; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Arthritis National Research Foundation; U.S. Department of Veterans Affairs; Foundation for the National Institutes of Health","keywords":"Psoriasis; Genome-wide association study; Genetic architecture; Heritability; Genetics; Genetic association; Biology; Meta-analysis; Computational biology; Medicine; Quantitative trait locus; Single-nucleotide polymorphism; Immunology; Gene; Genotype; Internal medicine","authors":[{"name":"Lam C. Tsoi","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"Chao Tian","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Sayantan Das","is_ca":false},{"name":"Matthew Zawistowski","is_ca":false},{"name":"Eva Ellinghaus","is_ca":false},{"name":"Vinod Chandran","is_ca":true},{"name":"Nick Dand","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Charlotta Enerbäck","is_ca":false},{"name":"Tõnu Esko","is_ca":false},{"name":"André Franke","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Per Hoffmann","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Andres Metspalu","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"Sören Mucha","is_ca":false},{"name":"Proton Rahman","is_ca":true},{"name":"André Reis","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Richard C. Trembath","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Stephan Weidinger","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"Xiaoquan Wen","is_ca":false},{"name":"Nicholas Eriksson","is_ca":false},{"name":"Hyun Min Kang","is_ca":false},{"name":"David A. Hinds","is_ca":false},{"name":"Rajan P. Nair","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1216175602596136,"gpt":0.3777229581284424,"spread":0.2561053978688288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004628494,0.0009345877,0.003374432,0.002528034,0.000190779,0.001216681,0.001086409,0.0008170584,0.002049815],"category_scores_gemma":[0.006529298,0.0003877161,0.004507822,0.003438873,0.0003216257,0.0004154765,0.0006209476,0.0008795207,0.0002003823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005497469,"about_ca_system_score_gemma":0.0008356678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001105259,"about_ca_topic_score_gemma":0.002463223,"domain_scores_codex":[0.998092,0.0009846413,0.0001959409,0.000340686,0.0003150245,0.0000716643],"domain_scores_gemma":[0.993996,0.004565037,0.0006999569,0.0002631343,0.000372958,0.0001029704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003446253,0.00008529254,0.08707245,0.06201113,0.2409281,0.001306734,0.0001376843,0.00415143,0.003469199,0.0028114,0.0109187,0.5836617],"study_design_scores_gemma":[0.001409684,0.001169228,0.3060902,0.01721626,0.5370057,0.006306406,0.0002888808,0.005872684,0.003583987,0.01891682,0.1018977,0.0002422304],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00721397,0.9899195,0.001527,0.0005392854,0.0001109271,0.00001878425,0.0002768007,0.00003101403,0.0003626607],"genre_scores_gemma":[0.249548,0.7449161,0.002905084,0.0006816636,0.0004965204,0.00007810852,0.0009495568,0.00003817328,0.0003867495],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004628494,"threshold_uncertainty_score":0.02447814,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034585843","doi":"10.1001/jama.290.23.3073","title":"Efalizumab for Patients With Moderate to Severe Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":397,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Placebo; Adverse effect; Severity of illness; Internal medicine; Dermatology; Plaque psoriasis; Randomized controlled trial; Visual analogue scale; Surgery; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Tiffani K. Hamilton","is_ca":false},{"name":"Patricia A. Walicke","is_ca":false},{"name":"Wolfgang Dummer","is_ca":false},{"name":"Nicole Li","is_ca":false},{"name":"Brian W. Bresnahan","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01132498776174481,"gpt":0.2192114849151484,"spread":0.2078864971534036,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005988699,0.0004914011,0.00140321,0.0002256043,0.0003763158,0.0003028322,0.0002174459,0.0006658667,0.003024653],"category_scores_gemma":[0.001002312,0.0001921044,0.0005961595,0.0002710249,0.0002372543,0.0002838739,0.0001597246,0.0008100484,0.0004754132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002417502,"about_ca_system_score_gemma":0.000487682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006510783,"about_ca_topic_score_gemma":0.001592996,"domain_scores_codex":[0.9997607,0.0001148897,0.00002177305,0.00002832471,0.00003355677,0.00004062938],"domain_scores_gemma":[0.999688,0.00009668915,0.0000739598,0.00001140736,0.00002188454,0.000107924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3429954,0.01024911,0.05902741,0.00473187,0.002077372,0.002491108,0.0003941419,0.001076325,0.03494101,0.0004236186,0.01481513,0.5267775],"study_design_scores_gemma":[0.3836351,0.234584,0.3222863,0.0007681795,0.003704539,0.009049713,0.000320136,0.002219215,0.005552971,0.0008682245,0.03693222,0.00007939019],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9577841,0.03365317,0.000618694,0.002169296,0.0003052135,0.0009703848,0.0003173837,0.00009890545,0.004082923],"genre_scores_gemma":[0.9904665,0.005681613,0.000779026,0.001277623,0.0003377812,0.0003085062,0.0002457668,0.000004708637,0.0008985149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003024653,"threshold_uncertainty_score":0.01011854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132938540","doi":"10.4049/jimmunol.175.1.404","title":"Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis","year":2005,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":395,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Cystic fibrosis; Granulocyte colony-stimulating factor receptor; Inflammation; Epithelium; Respiratory epithelium; Granulocyte colony-stimulating factor; Interleukin 17; Immunology; Granulocyte; Medicine; Airway; Receptor; Cancer research; Biology; Internal medicine; Pathology","authors":[{"name":"Florencia McAllister","is_ca":false},{"name":"Adam C. Henry","is_ca":false},{"name":"James L. Kreindler","is_ca":false},{"name":"Patricia J. Dubin","is_ca":false},{"name":"Lauren Ulrich","is_ca":false},{"name":"Chad Steele","is_ca":false},{"name":"Jonathan D. Finder","is_ca":false},{"name":"Joseph M. Pilewski","is_ca":false},{"name":"Beatriz M. Carreno","is_ca":true},{"name":"Samuel J. Goldman","is_ca":true},{"name":"Jaana Pirhonen","is_ca":false},{"name":"Jay K. Kolls","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009079376718189737,"gpt":0.2303342768316972,"spread":0.2212549001135075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002260183,0.0003257571,0.0002762458,0.0005417931,0.0002174613,0.0005643844,0.0001524436,0.0003594663,0.0006757182],"category_scores_gemma":[0.000264797,0.0001785176,0.0002691672,0.0001415676,0.0004869881,0.0003382128,0.0002512368,0.0005028642,0.0002885503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003379044,"about_ca_system_score_gemma":0.0003926018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005859478,"about_ca_topic_score_gemma":0.0005345494,"domain_scores_codex":[0.9998398,0.00003949804,0.0000100527,0.00002065065,0.00004069029,0.00004939634],"domain_scores_gemma":[0.9998522,0.00002698678,0.00003382573,0.00001082453,0.00002067674,0.00005556132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001052009,0.00009629687,0.01447188,0.0001925104,0.00002711318,0.001110849,0.0001271644,0.0001690076,0.9679519,0.0003092035,0.0001262438,0.01436588],"study_design_scores_gemma":[0.0002207333,0.002096795,0.2613635,0.0001999148,0.0002248121,0.008230978,0.0008080748,0.004275346,0.7067817,0.001011033,0.01475597,0.00003118667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616117,0.03472425,0.00173319,0.0006012532,0.00004387154,0.00002254001,0.0001177176,0.00003894253,0.001106605],"genre_scores_gemma":[0.9879279,0.009583646,0.001308611,0.0001415627,0.00006650989,0.00003983792,0.0001276668,0.00001082729,0.0007933942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006757182,"threshold_uncertainty_score":0.002451658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138647255","doi":"10.1016/s0140-6736(14)62113-9","title":"Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":394,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Tofacitinib; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Janus kinase inhibitor; Population; Randomized controlled trial; Surgery; Dermatology; Rheumatoid arthritis","authors":[{"name":"H. Bachelez","is_ca":false},{"name":"P.C.M. van de Kerkhof","is_ca":false},{"name":"Robert Strohal","is_ca":false},{"name":"А. А. Кубанов","is_ca":false},{"name":"Fernando Valenzuela","is_ca":true},{"name":"Joo‐Heung Lee","is_ca":false},{"name":"V. V. Yakusevich","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Jocelyne Papacharalambous","is_ca":false},{"name":"James Proulx","is_ca":false},{"name":"Pankaj Gupta","is_ca":false},{"name":"Huaming Tan","is_ca":false},{"name":"Margaret Tawadrous","is_ca":false},{"name":"Hernán Valdez","is_ca":false},{"name":"Robert Wołk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07837364539587272,"gpt":0.324495817594725,"spread":0.2461221721988522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002297723,0.002401658,0.004232562,0.0004429735,0.000559098,0.001914746,0.001032334,0.002686596,0.01200853],"category_scores_gemma":[0.002117051,0.0008277304,0.003718285,0.000458979,0.001265426,0.001591614,0.0005280725,0.004758311,0.00165856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001187564,"about_ca_system_score_gemma":0.0009138623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001388916,"about_ca_topic_score_gemma":0.002471199,"domain_scores_codex":[0.9991959,0.0003706247,0.00004933073,0.0001495209,0.00006364183,0.0001710646],"domain_scores_gemma":[0.9990087,0.0004019692,0.0001932621,0.00008785902,0.00005728797,0.0002509597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9875402,0.001174363,0.0001815429,0.0005580051,0.001179085,0.00003711,0.00002758404,0.000191467,0.00115377,0.0001141952,0.0008275505,0.007015043],"study_design_scores_gemma":[0.9879315,0.0101117,0.0005875831,0.0000338763,0.0004304718,0.00002541276,0.00001357162,0.0001303562,0.00007886006,0.0002019909,0.0004456154,0.000008996662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9470921,0.02730052,0.002052657,0.00382889,0.003022377,0.004436397,0.003516966,0.0003954506,0.008354691],"genre_scores_gemma":[0.9718963,0.00790394,0.001834596,0.003775415,0.001284625,0.003442465,0.001835742,0.00007964463,0.007947205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01200853,"threshold_uncertainty_score":0.04017252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053127888","doi":"10.1056/nejmoa1315231","title":"Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Monoclonal antibody; Monoclonal; Ixekizumab; Immunology; Arthritis; Antibody; Dermatology; Secukinumab","authors":[{"name":"Philip J. Mease","is_ca":false},{"name":"Mark C. Genovese","is_ca":false},{"name":"Maria Greenwald","is_ca":false},{"name":"Christopher T. Ritchlin","is_ca":false},{"name":"André Beaulieu","is_ca":true},{"name":"Atul Deodhar","is_ca":false},{"name":"Richard Newmark","is_ca":false},{"name":"JingYuan Feng","is_ca":false},{"name":"Ngozi Erondu","is_ca":false},{"name":"Ajay Nirula","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01403969140501073,"gpt":0.2641910178317347,"spread":0.2501513264267239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002402259,0.0005338842,0.0009356398,0.0003665518,0.0002147376,0.0004750802,0.0005103503,0.0007407788,0.001767129],"category_scores_gemma":[0.001036972,0.000267139,0.0005426986,0.0002433871,0.0004446624,0.0003335941,0.0001785377,0.001147818,0.0003893074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002439089,"about_ca_system_score_gemma":0.0005013138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002106206,"about_ca_topic_score_gemma":0.0006964762,"domain_scores_codex":[0.9993817,0.0003118899,0.00006692557,0.00006998345,0.00009734065,0.00007213179],"domain_scores_gemma":[0.9992886,0.0002383102,0.0002076944,0.0000353668,0.00007724715,0.0001527447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1942875,0.02130267,0.02084022,0.007806958,0.001564492,0.0007429295,0.0002098823,0.001706484,0.1255854,0.000395059,0.003386267,0.6221722],"study_design_scores_gemma":[0.3708397,0.4763656,0.08525065,0.0009292098,0.003533958,0.003983639,0.0001244457,0.002754183,0.0339515,0.0005650772,0.02160476,0.00009716512],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8946455,0.100233,0.0009757156,0.001213918,0.0003879587,0.0005047041,0.00017516,0.00007404439,0.001789961],"genre_scores_gemma":[0.9739903,0.02078694,0.002318813,0.001234121,0.0005469733,0.0002456976,0.0001785367,0.000008328082,0.0006903005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002402259,"threshold_uncertainty_score":0.01270455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168503185","doi":"10.1056/nejmoa066886","title":"Etanercept Treatment for Children and Adolescents with Plaque Psoriasis","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":388,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nexus Clinical Research (Canada); Dalhousie University","funders":"National Psoriasis Foundation; Amgen","keywords":"Etanercept; Medicine; Psoriasis; Plaque psoriasis; Dermatology; Tumor necrosis factor alpha; Internal medicine","authors":[{"name":"Amy S. Paller","is_ca":false},{"name":"Elaine C. Siegfried","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"David M. Pariser","is_ca":false},{"name":"Ian Landells","is_ca":true},{"name":"Adelaide A. Hebert","is_ca":false},{"name":"Lawrence F. Eichenfield","is_ca":false},{"name":"Vaishali Patel","is_ca":false},{"name":"Kara Creamer","is_ca":false},{"name":"Angelika Jahreis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01799847982952313,"gpt":0.2390666548705623,"spread":0.2210681750410392,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002910577,0.0002139589,0.0006753692,0.0001581365,0.0002371109,0.0002044297,0.00013913,0.0003005129,0.001739145],"category_scores_gemma":[0.0005508444,0.00009621007,0.000374166,0.0002065613,0.000138379,0.0001376851,0.0001335882,0.0006817543,0.0002811052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003013044,"about_ca_system_score_gemma":0.0005916635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008466105,"about_ca_topic_score_gemma":0.002292539,"domain_scores_codex":[0.9998286,0.00006797902,0.0000211305,0.00001945193,0.00003239377,0.00003044254],"domain_scores_gemma":[0.9996647,0.00008679488,0.0001098023,0.0000094647,0.00003558253,0.00009375265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02340055,0.004069896,0.3602034,0.004077991,0.001074263,0.0127462,0.0009521284,0.001280027,0.03486286,0.001438074,0.0245953,0.5312994],"study_design_scores_gemma":[0.02733343,0.04123978,0.7079625,0.002479049,0.00233629,0.06386627,0.001257607,0.001695564,0.012824,0.0008242083,0.1381303,0.00005103903],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9564127,0.03580399,0.0004401806,0.001328419,0.0001744351,0.0001970589,0.0003854416,0.00003925517,0.005218452],"genre_scores_gemma":[0.9843267,0.01200397,0.00118874,0.0008360629,0.0001415039,0.0001937713,0.0003540221,0.000007015392,0.0009482896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001739145,"threshold_uncertainty_score":0.005818009,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019217317","doi":"10.1046/j.1523-1747.2003.12040.x","title":"Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study","year":2003,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":385,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Skin cancer; Incidence (geometry); Population; Prospective cohort study; Internal medicine; Dermatology; Cohort; Basal cell carcinoma; Cohort study; Cancer; Surgery; Gastroenterology; Basal cell","authors":[{"name":"C. Paul","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Claire McGeown","is_ca":false},{"name":"Enno Christophers","is_ca":false},{"name":"Birgit Schmidtmann","is_ca":false},{"name":"Jean-Claude Guillaume","is_ca":false},{"name":"Véronique Lamarque","is_ca":false},{"name":"Louis Dubertret","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01134483080681904,"gpt":0.2211599671607557,"spread":0.2098151363539367,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006090811,0.0006579655,0.0008445032,0.0008625478,0.001179511,0.001015577,0.0005475612,0.001264144,0.001891423],"category_scores_gemma":[0.001128391,0.0008945646,0.001407112,0.001237378,0.0003962355,0.0007850956,0.0004400203,0.001433843,0.0003827479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003965062,"about_ca_system_score_gemma":0.0004954641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01372256,"about_ca_topic_score_gemma":0.006809418,"domain_scores_codex":[0.99942,0.0001426149,0.00004321707,0.0001612045,0.00007304565,0.0001599074],"domain_scores_gemma":[0.9990362,0.0001191955,0.0002959171,0.0001220836,0.00009631781,0.000330308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00289389,0.0005769932,0.9914927,0.000007911756,0.0003211703,0.0007488615,0.0002323438,0.00007790994,0.002259609,0.000030333,0.0001254835,0.001232718],"study_design_scores_gemma":[0.0001139769,0.0009159997,0.9970888,0.000003309134,0.0001783891,0.000826679,0.0002570612,0.0002352436,0.0001579282,0.00002021212,0.000190732,0.00001155556],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994115,0.0001183905,0.00005824113,0.00003278843,0.000006669171,0.00000705297,0.0001268486,0.000003976822,0.0002345084],"genre_scores_gemma":[0.999313,0.00009947364,0.00005106211,0.00003670895,0.0000134807,0.000007970921,0.0001724921,0.00000333744,0.0003024737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01372256,"threshold_uncertainty_score":0.0272854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}